https://curecurrent.com/trials/a-phase-i-study-of-the-safety-and-pharmacokinetics-of-recombinant-human-cd4-immunoglobulin-g-rcd4-igg-administered-by-in-134009https://curecurrent.com/trials/a-comparison-of-hiv-infected-patients-with-and-without-opportunistic-aids-related-infection-134010https://curecurrent.com/trials/the-safety-and-effectiveness-of-clarithromycin-plus-zidovudine-or-dideoxyinosine-in-the-treatment-of-mycobacterium-avium-134011https://curecurrent.com/trials/safety-and-efficacy-of-polyethylene-glycolated-il-2-peg-il-2-plus-zidovudine-in-hiv-positive-asymptomatic-and-symptomati-134012https://curecurrent.com/trials/the-pharmacokinetics-of-zidovudine-and-oxazepam-alone-and-in-combination-in-the-hiv-infected-patient-134013https://curecurrent.com/trials/the-safety-and-effectiveness-of-bi-rg-587-in-hiv-infected-patients-134014https://curecurrent.com/trials/a-randomized-study-of-activity-safety-and-tolerance-of-oral-ro-24-7429-tat-antagonist-in-patients-with-hiv-infection-134015https://curecurrent.com/trials/setting-up-a-blood-bank-for-gene-therapy-in-hiv-infected-infants-134016https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-anti-hiv-drugs-in-hiv-positive-patients-who-also-have-hepatitis-c-infection-134017https://curecurrent.com/trials/withdrawal-of-antifungal-treatment-for-histoplasmosis-in-patients-after-improved-immune-response-to-anti-hiv-drugs-134018https://curecurrent.com/trials/daily-nevirapine-to-prevent-mother-to-infant-transmission-of-hiv-134019https://curecurrent.com/trials/the-effects-of-valproic-acid-on-zidovudine-glucuronidation-and-pharmacokinetics-in-hiv-infected-patients-134020https://curecurrent.com/trials/the-safety-and-effectiveness-of-a-type-of-interleukin-2-plus-zidovudine-plus-thymosin-in-hiv-positive-patients-with-and-134021https://curecurrent.com/trials/treatment-of-hepatitis-c-in-hemophilic-patients-with-hiv-134022https://curecurrent.com/trials/a-study-of-immune-system-activity-in-healthy-adults-134023https://curecurrent.com/trials/effects-of-storage-on-lactate-in-blood-samples-134024https://curecurrent.com/trials/the-effects-of-anti-hiv-drugs-on-the-hiv-virus-in-hiv-infected-patients-134025https://curecurrent.com/trials/a-pharmacokinetic-study-of-l-697-661-alone-and-in-combination-with-zidovudine-134026https://curecurrent.com/trials/a-blood-test-to-look-at-cells-of-the-immune-system-in-healthy-children-134027https://curecurrent.com/trials/a-study-to-examine-the-effects-of-stopping-preventive-therapy-for-disseminated-mycobacterium-avium-complex-dmac-in-hiv-p-134028https://curecurrent.com/trials/a-study-to-demonstrate-that-anti-hiv-drug-therapy-can-be-stopped-without-causing-viral-resistance-and-to-characterize-dr-134029https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-stopping-maintenance-therapy-for-cytomegalovirus-cmv-retinitis-after-effective-anti-h-134030https://curecurrent.com/trials/safety-and-tolerability-of-the-vaginal-gel-pro-2000-5-134031https://curecurrent.com/trials/an-open-label-staggered-rising-dose-cohort-study-assessing-the-pharmacokinetics-safety-and-tolerance-of-bi-rg-587-in-com-134032https://curecurrent.com/trials/comparing-single-photon-emission-computed-tomography-spect-and-liver-biopsy-to-evaluate-the-liver-in-patients-with-hiv-a-134033https://curecurrent.com/trials/effectiveness-of-adding-remune-to-your-current-anti-hiv-drug-combination-134034https://curecurrent.com/trials/ritonavir-boosted-gs-9137-vs-ritonavir-boosted-protease-inhibitor-s-in-combination-with-background-art-134035https://curecurrent.com/trials/hiv-levels-in-cerebrospinal-fluid-and-brain-function-in-patients-receiving-anti-hiv-drugs-134036https://curecurrent.com/trials/evaluation-of-the-changes-in-hiv-1-burden-in-peripheral-blood-and-lymphoid-tissue-following-zidovudine-azt-treatment-in-134037https://curecurrent.com/trials/social-psychological-intervention-to-improve-adherence-to-haart-134038https://curecurrent.com/trials/a-study-of-zidovudine-in-infants-exposed-to-the-hiv-before-or-soon-after-birth-134039https://curecurrent.com/trials/efficacy-of-simplified-two-drug-kaletra-regimen-vs-kaletra-triple-drug-standard-of-care-regimen-in-treatment-na-ve-hiv-i-134040https://curecurrent.com/trials/the-detection-of-drug-resistant-hiv-1-in-taiwan-134041https://curecurrent.com/trials/the-human-immunodeficiency-virus-and-osteopathic-manipulation-evaluation-study-134042https://curecurrent.com/trials/durability-of-nevirapine-based-antiretroviral-regimen-134043https://curecurrent.com/trials/sweet-once-daily-truvada-versus-twice-daily-combivir-for-the-treatment-of-hiv-infection-134044https://curecurrent.com/trials/tenofovir-df-efavirenz-tdf-efv-versus-tenofovir-df-efavirenz-lamivudine-tdf-efv-3tc-maintenance-regimen-in-virologically-134045https://curecurrent.com/trials/clinical-sensitivity-of-clearview-rapid-tests-in-12-17-y-o-pediatric-population-134046https://curecurrent.com/trials/phase-2b-dose-ranging-study-of-pac113-mouthrinse-in-hiv-seropositive-individuals-with-oral-candidiasis-134047https://curecurrent.com/trials/novel-internet-based-interventions-to-reduce-sexual-risk-among-men-who-have-sex-with-men-134048https://curecurrent.com/trials/effect-of-multiple-micronutrient-supplementation-on-growth-morbidity-and-mortality-of-hiv-infected-children-in-uganda-134049https://curecurrent.com/trials/short-course-intermittent-regimens-for-the-treatment-of-hiv-associated-tuberculosis-134050https://curecurrent.com/trials/sonett-switch-study-to-once-daily-hiv-treatment-regimen-with-truvada-134051https://curecurrent.com/trials/aids-vaccine-study-comparing-immunogenicity-and-safety-of-3-doses-of-lipopeptides-versus-placebo-in-non-infected-hiv-vol-134052https://curecurrent.com/trials/cotrimoxazole-prophylaxis-cessation-study-among-stabilized-hiv-infected-adult-patients-on-haart-in-entebbe-uganda-134053https://curecurrent.com/trials/testing-the-effectiveness-of-voices-as-implemented-by-std-hiv-prevention-agencies-in-the-us-and-pr-134054https://curecurrent.com/trials/male-circumcision-and-hiv-rates-in-kenya-134055https://curecurrent.com/trials/pharmacokinetic-study-of-the-vaginal-microbicide-agent-1-tenofovir-gel-134056https://curecurrent.com/trials/evolution-of-l74v-or-k65r-mutations-in-viremic-subjects-on-tenofovir-disoproxil-fumarate-tdf-or-abacavir-abc-evita-134057https://curecurrent.com/trials/role-of-the-autonomic-nervous-system-in-hiv-lipodystrophy-134058https://curecurrent.com/trials/gene-therapy-with-gx-12-in-combination-with-haart-for-the-hiv-1-infected-patients-134059https://curecurrent.com/trials/single-dose-versus-two-weeks-course-of-fluconazole-in-the-treatment-of-oropharyngeal-candidiasis-in-hiv-infected-individ-134060https://curecurrent.com/trials/nevirapine-plus-zidovudine-to-prevent-perinatal-hiv-in-thailand-134061https://curecurrent.com/trials/prevalence-of-proteinuria-and-chronic-kidney-disease-in-pediatric-hiv-infected-patients-134062https://curecurrent.com/trials/shortened-zidovudine-regimens-to-prevent-mother-to-child-transmission-of-hiv-type-1-134063https://curecurrent.com/trials/hiv-vertical-transmission-in-vietnam-134064https://curecurrent.com/trials/long-term-treatment-interruptions-134065https://curecurrent.com/trials/painful-hiv-neuropathy-and-alpha-lipoic-acid-134066https://curecurrent.com/trials/follow-up-on-the-high-low-study-the-longterm-effects-of-growth-hormone-134067https://curecurrent.com/trials/correlation-between-intestinal-parasites-and-serum-level-of-eosinophils-and-ige-in-individuals-with-hiv-or-aids-134068https://curecurrent.com/trials/a-surveillance-program-for-the-detection-of-hepatitis-b-virus-hbv-resistance-to-tenofovir-in-hiv-hbv-co-infected-patient-134069https://curecurrent.com/trials/safety-study-of-nasal-hiv-vaccine-adjuvanted-with-ltk63-134070https://curecurrent.com/trials/treatment-of-classical-non-hiv-related-kaposi-s-sarcoma-with-the-antiviral-drug-indinavir-134071https://curecurrent.com/trials/metabolic-effects-of-enfuvirtide-in-healthy-volunteers-134072https://curecurrent.com/trials/combination-of-efavirenz-and-truvada-comet-study-134073https://curecurrent.com/trials/an-open-label-study-of-emtricitabine-in-combination-with-other-antiretroviral-agents-in-hiv-infected-pediatric-subjects-134074https://curecurrent.com/trials/single-tablet-regimen-str-simplification-study-for-hiv-1-infected-patients-134075https://curecurrent.com/trials/phase-ii-comparator-study-of-substitution-of-tenofovir-or-abacavir-receiving-thymidine-analogue-as-part-of-haart-134076https://curecurrent.com/trials/efficacy-and-safety-of-kaletra-monotheraphy-compared-to-kaletra-based-triple-therapy-to-treat-hiv-in-antiretroviral-na-v-134077https://curecurrent.com/trials/abt-378-ritonavir-in-combination-with-reverse-transcriptase-inhibitors-in-antiretroviral-na-ve-hiv-infected-subjects-134078https://curecurrent.com/trials/nevirapine-study-for-the-prevention-of-maternal-infant-hiv-transmission-in-uganda-134079https://curecurrent.com/trials/hiv-hbv-co-infection-and-liver-disease-134080https://curecurrent.com/trials/dronabinol-versus-placebo-in-treatment-and-prevention-of-highly-active-anti-retroviral-therapy-haart-related-nausea-and-134081https://curecurrent.com/trials/amprenavir-ritonavir-saquinavir-ritonavir-or-efavirenz-in-hiv-infected-subjects-following-failure-with-kaletra-abt-378-r-134082https://curecurrent.com/trials/metabolic-impact-assessment-of-tenofovir-disoproxil-fumarate-on-non-hiv-1-infected-healthy-adult-male-volunteers-134083https://curecurrent.com/trials/strategies-of-interruption-reinitiation-of-antiretroviral-therapy-in-hiv-infected-patients-with-lipodystrophy-134084https://curecurrent.com/trials/study-of-the-effectiveness-of-passive-immunotherapy-in-hiv-infected-patients-who-are-in-virologic-failure-134085https://curecurrent.com/trials/three-generic-nevirapine-based-antiretroviral-treatments-in-chinese-patients-multicentric-observation-cohort-134086https://curecurrent.com/trials/safety-of-the-envpro-hiv-vaccine-in-healthy-volunteers-134087https://curecurrent.com/trials/ok-2004-study-only-kaletra-2004-study-study-to-evaluate-suspending-nucleosides-from-triple-drug-therapy-in-hiv-subjects-134088https://curecurrent.com/trials/buprenorphine-hiv-care-integration-project-134089https://curecurrent.com/trials/omacor-and-cardiovascular-risk-factors-in-hiv-patients-on-haart-treatment-134090https://curecurrent.com/trials/acupuncture-and-moxa-a-randomized-clinical-trial-for-chronic-diarrhea-in-hiv-patients-134091https://curecurrent.com/trials/treatment-of-depression-with-massage-in-hiv-134092https://curecurrent.com/trials/study-of-ngx-4010-for-the-treatment-of-painful-hiv-associated-neuropathy-134093https://curecurrent.com/trials/study-of-ngx-4010-for-the-treatment-of-painful-hiv-associated-neuropathy-hiv-an-or-postherpetic-neuralgia-phn-134094https://curecurrent.com/trials/study-of-ngx-4010-for-treatment-of-painful-hiv-associated-neuropathy-134095https://curecurrent.com/trials/interleukin-2-therapy-for-hiv-infection-supplemental-procedures-134096https://curecurrent.com/trials/the-effect-of-milk-thistle-on-the-pharmacokinetics-of-indinavir-134097https://curecurrent.com/trials/subcutaneously-administered-interleukin-12-therapy-in-hiv-infected-patients-with-disseminated-mycobacterium-avium-comple-134098https://curecurrent.com/trials/a-pilot-study-of-the-combination-of-retinoic-acid-and-interferon-alpha2a-for-the-treatment-of-lymphoproliferative-disord-134099https://curecurrent.com/trials/a-randomized-pilot-study-for-the-treatment-of-aids-or-aids-related-complex-with-an-alternating-or-simultaneous-combinati-134100https://curecurrent.com/trials/endothelial-dysfunction-as-a-risk-factor-in-hiv-study-134101https://curecurrent.com/trials/hiv-maintenance-therapy-with-t-20-during-haart-interruption-134102https://curecurrent.com/trials/effect-of-tenofovir-df-on-bone-metabolism-in-children-134103https://curecurrent.com/trials/effects-of-hiv-on-the-development-and-function-of-bone-marrow-cells-134104https://curecurrent.com/trials/prediction-and-testing-of-antigenic-sites-of-the-aids-virus-htlv-iii-recognized-by-t-lymphocytes-for-the-development-of-134105https://curecurrent.com/trials/a-controlled-prospective-study-of-transfusion-associated-hepatitis-134106https://curecurrent.com/trials/observation-of-hiv-infected-children-receiving-protease-inhibitor-and-reverse-transcriptase-inhibitor-134107https://curecurrent.com/trials/a-phase-i-ii-study-of-the-protease-inhibitor-indinavir-mk-0639-in-children-with-hiv-infection-134108https://curecurrent.com/trials/drug-interactions-among-anti-hiv-agents-134109https://curecurrent.com/trials/lamivudine-and-adefovir-to-treat-chronic-hepatitis-b-infection-in-people-with-and-without-hiv-infection-134110https://curecurrent.com/trials/kidney-transplant-for-hiv-infected-patients-in-renal-failure-134111https://curecurrent.com/trials/a-pilot-study-of-non-hodgkin-s-lymphoma-chemotherapy-and-blood-levels-of-organochlorines-134112https://curecurrent.com/trials/immune-activity-against-cvm-retinitis-134113https://curecurrent.com/trials/a-pilot-study-of-the-immunologic-reconstitution-in-hiv-1-infected-children-receiving-highly-active-antiretroviral-therap-134114https://curecurrent.com/trials/correlation-of-hiv-levels-with-clinical-and-immunologic-outcome-in-children-treated-with-didanosine-134115https://curecurrent.com/trials/interluekin-7-to-treat-hiv-infected-people-receiving-antiretroviral-treatment-134116https://curecurrent.com/trials/the-effect-of-oral-candidiasis-on-the-speech-production-feeding-skills-and-self-concept-of-children-and-adolescents-with-134117https://curecurrent.com/trials/intermittent-versus-continuous-medication-in-the-treatment-of-hiv-134118https://curecurrent.com/trials/genetic-factors-and-interrelationships-for-sexual-orientation-susceptibility-to-hiv-and-kaposi-s-sarcoma-alcoholism-and-134119https://curecurrent.com/trials/combination-drug-treatment-of-pediatric-hiv-infection-134120https://curecurrent.com/trials/white-blood-cell-infusions-to-treat-hiv-infection-134121https://curecurrent.com/trials/voriconazole-vs-amphotericin-b-in-the-treatment-of-invasive-aspergillosis-134122https://curecurrent.com/trials/intermittent-vs-continuous-haart-to-treat-chronic-hiv-infection-134123https://curecurrent.com/trials/pharmacokinetics-of-antiretroviral-agents-in-hiv-1-infected-pregnant-women-134124https://curecurrent.com/trials/subcutaneously-administered-interleukin-2-therapy-in-hiv-infected-patients-134125https://curecurrent.com/trials/thalidomide-to-treat-oral-lesions-in-hiv-infected-patients-134126https://curecurrent.com/trials/a-phase-i-ii-study-of-the-combination-of-azidothymidine-and-interleukin-2-il-2-in-the-treatment-of-hiv-infected-patients-134127https://curecurrent.com/trials/genetically-modified-lymphocytes-to-treat-hiv-infected-identical-twins-study-modifications-134128https://curecurrent.com/trials/evaluation-of-hiv-negative-patients-with-low-cd4-t-lymphocyte-counts-134129https://curecurrent.com/trials/phase-i-study-of-apl-400-003-a-candidate-hiv-vaccine-in-hiv-negative-volunteers-134130https://curecurrent.com/trials/a-pilot-study-of-adherence-to-oral-medication-and-health-beliefs-of-adolescents-with-hiv-and-their-mothers-134131https://curecurrent.com/trials/the-effect-of-lopinavir-ritonavir-on-endothelial-function-134132https://curecurrent.com/trials/evaluation-and-natural-history-of-children-with-cancer-and-aids-134133https://curecurrent.com/trials/continued-antiretroviral-therapy-with-abacavir-amprenavir-and-efavirenz-134134https://curecurrent.com/trials/the-impact-of-haart-on-response-to-hepatitis-c-treatment-in-patients-taking-peginterferon-alpha-2b-and-ribavirin-134135https://curecurrent.com/trials/genetic-factors-and-interrelationships-for-cancer-risk-related-behaviors-and-complex-traits-134136https://curecurrent.com/trials/home-treatment-of-hiv-infected-patients-with-interleukin-2-with-or-without-a-tumor-necrosis-factor-antagonist-134137https://curecurrent.com/trials/tenofovir-disoproxil-fumarate-to-treat-pediatric-hiv-134138https://curecurrent.com/trials/influences-on-hiv-infected-subjects-willingness-to-participate-in-research-and-ability-to-give-informed-consent-134139https://curecurrent.com/trials/phase-i-protocol-for-the-evaluation-of-the-safety-and-immunogenicity-of-vaccination-with-synthetic-hiv-envelope-peptides-134140https://curecurrent.com/trials/the-use-of-bacteriophage-phi-x174-to-assess-the-immune-competence-of-hiv-infected-patients-in-vivo-134141https://curecurrent.com/trials/stem-cell-modified-bone-marrow-transplantation-in-hiv-infected-patients-with-blood-cancer-134142https://curecurrent.com/trials/gw873140-to-treat-hiv-1-infected-adults-134143https://curecurrent.com/trials/interventions-to-decrease-the-risk-of-mother-to-child-transmission-of-hiv-in-india-134144https://curecurrent.com/trials/a-pilot-study-of-the-patterns-of-cellular-gene-expression-in-hiv-1-patients-following-clinical-events-which-increase-pla-134145https://curecurrent.com/trials/adefovir-dipivoxil-to-treat-hepatitis-b-in-hiv-infected-patients-134146https://curecurrent.com/trials/long-term-survival-with-hiv-psychological-and-behavioral-factors-associated-with-the-transition-from-adolescence-to-youn-134147https://curecurrent.com/trials/immune-response-to-influenza-vaccine-in-hiv-infected-individuals-134148https://curecurrent.com/trials/a-study-of-health-related-quality-of-life-in-hiv-infected-patients-undergoing-structured-treatment-interruptions-of-high-134149https://curecurrent.com/trials/once-daily-drug-regimen-for-hiv-infected-patients-134150https://curecurrent.com/trials/metabolism-and-body-shape-of-healthy-children-and-children-with-chronic-infections-134151https://curecurrent.com/trials/determination-of-hiv-1-production-by-the-prostate-134152https://curecurrent.com/trials/pharmacodynamics-of-intermittent-il-2-infusions-in-hiv-seropositive-patients-134153https://curecurrent.com/trials/safety-and-anti-hiv-activity-of-capravirine-alone-and-in-combination-with-other-anti-hiv-drugs-134154https://curecurrent.com/trials/influenza-vaccine-in-hiv-infection-immune-response-and-effect-on-viral-load-134155https://curecurrent.com/trials/safety-and-survival-of-genetically-modified-white-blood-cells-in-hiv-infected-persons-a-study-in-identical-twin-pairs-134156https://curecurrent.com/trials/efficacy-of-elevated-cd4-counts-on-cmv-retinitis-134157https://curecurrent.com/trials/hiv-1-vaccine-test-in-uninfected-adult-volunteers-134158https://curecurrent.com/trials/phase-i-study-to-evaluate-the-safety-and-immunogenicity-of-hiv-1-immunogen-in-children-with-hiv-1-infection-134159https://curecurrent.com/trials/assessment-of-attentional-functioning-in-children-with-hiv-1-infection-134160https://curecurrent.com/trials/psychosocial-correlates-and-coping-strategies-associated-with-long-term-survival-of-hiv-infected-children-134161https://curecurrent.com/trials/therapeutic-drug-monitoring-and-viral-resistance-testing-in-the-treatment-of-hiv-infected-children-134162https://curecurrent.com/trials/fluconazole-prophylaxis-of-thrush-in-aids-134163https://curecurrent.com/trials/nucleic-acid-amplification-testing-nat-of-blood-donors-for-hcv-and-hiv-134164https://curecurrent.com/trials/fuzeon-enfuvirtide-early-access-program-for-patients-with-hiv-1-infection-134165https://curecurrent.com/trials/frequency-of-parenteral-and-non-parenteral-exposures-to-blood-among-healthcare-workers-at-the-clinical-center-nih-and-at-134166https://curecurrent.com/trials/study-on-the-effect-of-kaletra-nevirapine-as-maintenance-bitherapy-compared-to-a-triple-therapy-including-kaletra-analog-134167https://curecurrent.com/trials/medicinal-cannabis-for-painful-hiv-neuropathy-134168https://curecurrent.com/trials/efficacy-and-safety-to-extend-treatment-24-weeks-in-co-infected-hiv-hcv-genotype-1-and-or-4-134169https://curecurrent.com/trials/two-different-treatments-24-vs-48-weeks-chronic-hepatitis-c-genotypes-2-and-or-3-in-co-infected-hiv-hcv-134170https://curecurrent.com/trials/twins-study-of-gene-therapy-for-hiv-infection-134171https://curecurrent.com/trials/comparison-of-plasma-drug-levels-of-triomune-40-with-those-of-the-originator-products-134172https://curecurrent.com/trials/study-to-evaluate-the-effectiveness-of-abc-3tc-efv-in-once-daily-regimens-versus-klt-in-twice-daily-regimens-in-naive-hi-134173https://curecurrent.com/trials/computer-assisted-rx-education-for-hiv-positives-care-134174https://curecurrent.com/trials/immuno-virological-efficacy-of-combination-with-trizivir-tenofovir-in-multiresistant-hiv-patients-134175https://curecurrent.com/trials/antiretroviral-treatment-simplification-study-with-efavirenz-abacavir-3tc-once-daily-134176https://curecurrent.com/trials/the-effect-of-valacyclovir-on-the-detection-of-hiv-from-genital-herpes-lesions-in-hiv-infected-patients-134177https://curecurrent.com/trials/mindfulness-meditation-training-in-hiv-134178https://curecurrent.com/trials/the-efficacy-of-the-hiv-aids-symptom-management-manual-134179https://curecurrent.com/trials/spl7013-gel-male-tolerance-study-134180https://curecurrent.com/trials/a-study-of-valacyclovir-to-suppress-hsv-and-hiv-shedding-in-coinfected-persons-134181https://curecurrent.com/trials/study-of-kp-1461-for-the-treatment-of-hiv-positive-patients-who-have-failed-multiple-haart-regimens-134182https://curecurrent.com/trials/a-phase-1-safety-and-immunogenicity-study-of-the-epitope-based-dna-vaccine-ep-hiv-1090-in-hiv-1-infected-individuals-rec-134183https://curecurrent.com/trials/safer-choices-2-hiv-std-pregnancy-prevention-program-134184https://curecurrent.com/trials/study-evaluating-vaccine-in-adults-with-hiv-134185https://curecurrent.com/trials/study-evaluating-vaccine-in-adults-with-hiv-134186https://curecurrent.com/trials/efficacy-and-safety-of-addition-of-il-2-to-pegylated-interferon-alpha-2a-and-ribavirin-in-hiv-hcv-coinfected-patients-134187https://curecurrent.com/trials/treatment-of-helminth-co-infection-short-term-effects-on-hiv-1-progression-markers-and-immune-activation-134188https://curecurrent.com/trials/open-label-study-of-908-rtv-in-combination-with-other-pis-for-the-treatment-of-multi-pi-experienced-hiv-subjects-134189https://curecurrent.com/trials/longitudinal-study-of-haart-social-networks-adherence-134190https://curecurrent.com/trials/use-of-oraquick-for-screening-hiv-in-children-less-than-eighteen-months-old-134191https://curecurrent.com/trials/impact-of-drug-therapy-and-co-morbidities-on-the-development-of-renal-impairment-in-hiv-infected-patients-134192https://curecurrent.com/trials/video-tool-to-promote-knowledge-of-syphilis-as-facilitator-of-hiv-transmission-134193https://curecurrent.com/trials/share-simple-haart-with-abacavir-reyataz-and-epivir-134194https://curecurrent.com/trials/hepatitis-vaccination-in-hiv-infection-role-of-adjuvant-interleukin-2-134195https://curecurrent.com/trials/safety-of-and-immune-system-response-to-an-hiv-vaccine-ep-hiv-1090-in-hiv-infected-patients-134196https://curecurrent.com/trials/once-a-day-qd-twice-a-day-bid-clinical-trial-didanosine-lamivudine-and-efavirenz-versus-zidovudine-lamivudine-and-efavir-134197https://curecurrent.com/trials/four-drug-combination-treatment-in-hiv-infected-subjects-failing-therapy-with-antiretroviral-regimens-134198https://curecurrent.com/trials/safety-tolerance-and-acceptability-trial-of-the-invisible-condom-in-healthy-women-134199https://curecurrent.com/trials/a-randomized-controlled-trial-of-a-mindfulness-based-stress-reduction-intervention-for-men-living-with-hiv-134200https://curecurrent.com/trials/a-study-of-bv-arau-in-the-treatment-of-varicella-zoster-viral-disease-vzv-in-hiv-infected-children-who-have-not-had-succ-134201https://curecurrent.com/trials/a-study-of-lobucavir-in-patients-with-aids-134202https://curecurrent.com/trials/a-study-of-nystatin-in-the-prevention-of-fungal-infections-of-the-mouth-in-patients-with-aids-or-aids-related-syndromes-134203https://curecurrent.com/trials/the-safety-and-effectiveness-of-megace-in-hiv-infected-women-134204https://curecurrent.com/trials/a-comparison-of-two-anti-hiv-triple-drug-combinations-in-hiv-infected-patients-134205https://curecurrent.com/trials/nystatin-pastilles-for-the-prevention-of-oral-candidiasis-in-patients-with-aids-or-arc-134206https://curecurrent.com/trials/evaluation-of-amphotericin-b-in-the-treatment-of-biopsy-proven-candida-esophagitis-in-immunocompromised-patients-134207https://curecurrent.com/trials/a-comparison-of-epivir-plus-crixivan-combined-with-zerit-or-retrovir-in-hiv-infected-patients-who-have-never-taken-anti-134208https://curecurrent.com/trials/a-study-of-different-doses-of-megestrol-acetate-in-patients-with-aids-who-have-anorexia-and-malnutrition-134209https://curecurrent.com/trials/a-study-of-ddi-in-patients-with-aids-who-become-sicker-while-taking-zidovudine-134210https://curecurrent.com/trials/a-study-comparing-megestrol-acetate-at-800-mg-day-and-placebo-in-aids-patients-with-anorexia-and-cachexia-134211https://curecurrent.com/trials/nevirapine-resistance-study-nevirapine-resistance-among-hiv-infected-mothers-134212https://curecurrent.com/trials/lopinavir-ritonavir-in-combination-with-saquinavir-mesylate-or-lamivudine-zidovudine-to-explore-metabolic-toxicities-in-134213https://curecurrent.com/trials/antihyperlipidemic-effects-of-oyster-mushrooms-134214https://curecurrent.com/trials/a-comparative-phase-i-clinical-study-of-hivac-1e-and-smallpox-vaccinia-vaccines-in-previously-vaccinia-vaccinated-and-un-134215https://curecurrent.com/trials/prevention-of-perinatal-sepsis-pops-evaluation-of-chlorhexidine-wipes-of-birth-canal-and-newborn-134216https://curecurrent.com/trials/promoting-adherence-to-anti-hiv-drug-regimens-134217https://curecurrent.com/trials/vitamin-a-therapy-for-tuberculosis-134218https://curecurrent.com/trials/determining-an-effective-site-groin-versus-arm-for-giving-hiv-vaccines-134219https://curecurrent.com/trials/resistance-to-hiv-infection-134220https://curecurrent.com/trials/analysis-of-immune-responses-to-hiv-vaccines-134221https://curecurrent.com/trials/tuberculosis-in-hiv-infected-patients-in-uganda-134222https://curecurrent.com/trials/strategies-for-delivering-anti-hiv-therapy-in-south-africa-134223https://curecurrent.com/trials/pilot-study-of-high-concentration-capsaicin-patches-in-the-treatment-of-painful-hiv-associated-neuropathy-134224https://curecurrent.com/trials/risolubles-the-soluble-fraction-of-rice-bran-for-hiv-infected-patients-134225https://curecurrent.com/trials/long-term-supervised-treatment-interruption-in-hiv-infected-patients-134226https://curecurrent.com/trials/evaluation-of-the-safety-of-and-immune-response-to-an-hiv-vaccine-in-healthy-adults-134227https://curecurrent.com/trials/hiv-vaccine-designed-for-hiv-infected-adults-taking-anti-hiv-drugs-134228https://curecurrent.com/trials/therapeutic-vaccination-followed-by-treatment-interruption-in-hiv-infected-patients-134229https://curecurrent.com/trials/male-circumcision-for-hiv-prevention-in-rakai-uganda-134230https://curecurrent.com/trials/a-treatment-ind-investigational-new-drug-protocol-for-the-use-of-videx-2-3-dideoxyinosine-ddi-in-patients-with-acquired-134231https://curecurrent.com/trials/trial-of-male-circumcision-hiv-sexually-transmitted-disease-std-and-behavioral-effects-in-men-women-and-the-community-134232https://curecurrent.com/trials/treatment-of-cerebral-toxoplasmosis-in-hiv-aids-134233https://curecurrent.com/trials/supportive-therapy-for-adherence-to-art-staart-134234https://curecurrent.com/trials/phase-i-ii-open-label-trial-of-three-monoclonal-antibodies-134235https://curecurrent.com/trials/a-study-to-evaluate-the-use-of-nitazoxanide-to-treat-cryptosporidiosis-134236https://curecurrent.com/trials/study-comparing-racivir-and-lamivudine-in-treatment-experienced-hiv-subjects-134237https://curecurrent.com/trials/feasibility-study-of-a-once-daily-antiretroviral-regimen-in-vietnam-anrs-1210-vietar-134238https://curecurrent.com/trials/simple-once-daily-triple-regimen-including-tenofovir-emtricitabine-and-efavirenz-in-hiv-1-infected-patients-anrs-1207-134239https://curecurrent.com/trials/pediatric-nevirapine-resistance-study-134240https://curecurrent.com/trials/preventing-unplanned-pregnancies-in-hiv-infected-zambian-couples-134241https://curecurrent.com/trials/proalgazyme-novel-algae-infusion-applications-in-immunodeficiency-134242https://curecurrent.com/trials/marijuana-for-hiv-related-peripheral-neuropathy-134243https://curecurrent.com/trials/effects-of-creatine-and-resistance-exercise-training-in-people-with-hiv-infection-134244https://curecurrent.com/trials/treatment-of-hyperglycaemia-and-insulin-resistance-in-hiv-infected-patients-134245https://curecurrent.com/trials/effect-of-an-anti-inflammatory-drug-on-gut-mucosa-in-hiv-infected-patients-134246https://curecurrent.com/trials/safety-tolerance-pharmacokinetic-and-antiviral-study-of-amdoxovir-in-combination-with-zidovudine-in-adults-with-hiv-134247https://curecurrent.com/trials/2nn-charm-long-term-follow-up-study-134248https://curecurrent.com/trials/virological-and-clinical-anti-hepatitis-b-virus-hbv-efficacy-of-tenofovir-and-emtricitabine-in-patients-with-hiv-hbv-co-134249https://curecurrent.com/trials/succinylated-human-serum-albumin-suc-hsa-for-hiv-1-infection-134250https://curecurrent.com/trials/tolerability-of-peginterferon-plus-ribavirin-for-chronic-hepatitis-c-and-hiv-for-patients-receiving-antiretroviral-medic-134251https://curecurrent.com/trials/online-hiv-prevention-vignette-evaluation-134252https://curecurrent.com/trials/a-comparison-study-of-kaletra-soft-gel-capsules-and-kaletra-tablets-in-an-african-american-cohort-134253https://curecurrent.com/trials/buprenorphine-and-integrated-hiv-care-evaluation-134254https://curecurrent.com/trials/botanical-drug-interactions-in-hiv-glucuronidation-134255https://curecurrent.com/trials/botswana-tenofovir-oral-hiv-prophylaxis-trial-134256https://curecurrent.com/trials/safety-of-intradermal-versus-intramuscular-administration-of-hiv-lipopeptides-in-hiv-uninfected-adult-volunteers-134257https://curecurrent.com/trials/the-prevalence-of-vitamin-d-deficiency-and-effects-of-vitamin-d-supplementation-in-hiv-1-infected-patients-134258https://curecurrent.com/trials/cellulose-sulfate-cs-gel-and-hiv-in-nigeria-134259https://curecurrent.com/trials/multicenter-trial-of-immunologic-markers-to-predict-long-term-virologic-outcomes-134260https://curecurrent.com/trials/itv-extension-study-134261https://curecurrent.com/trials/determining-the-prevalence-of-hiv-related-neurological-disorders-in-the-asia-pacific-134262https://curecurrent.com/trials/randomized-controlled-trial-of-stress-management-training-in-hiv-134263https://curecurrent.com/trials/retinal-oxygen-reactivity-in-patients-infected-with-human-immunodeficiency-virus-hiv-134264https://curecurrent.com/trials/effect-of-nutritional-intervention-on-the-lipid-profile-of-hiv-positive-patients-who-start-haart-a-randomized-trial-134265https://curecurrent.com/trials/efficacy-and-tolerability-of-an-antiretroviral-bi-therapy-in-hiv-infected-patients-with-multidrug-resistance-134266https://curecurrent.com/trials/rituximab-in-the-treatment-of-hiv-associated-multicentric-castleman-disease-dependent-on-chemotherapy-134267https://curecurrent.com/trials/evaluation-of-three-regimens-of-chemoprophylaxis-for-tuberculosis-in-patients-co-infected-by-hiv-and-mycobacterium-tuber-134268https://curecurrent.com/trials/blade-comparison-of-once-daily-lopinavir-ritonavir-to-lopinavir-ritonavir-bid-dosing-in-hiv-infected-subjects-134269https://curecurrent.com/trials/a-study-of-buffergel-in-women-134270https://curecurrent.com/trials/staccato-a-trial-of-cd4-guided-treatment-interruption-compared-to-continuous-treatment-for-hiv-infection-134271https://curecurrent.com/trials/sp01a-the-study-of-an-oral-entry-inhibitor-in-treatment-experienced-hiv-patients-134272https://curecurrent.com/trials/study-comparing-reducing-the-dose-of-stavudine-versus-switching-to-tenofovir-in-hiv-infected-patients-receiving-antiretr-134273https://curecurrent.com/trials/mema-kwa-vijana-trial-impact-of-an-adolescent-sexual-and-reproductive-health-intervention-in-mwanza-tanzania-134274https://curecurrent.com/trials/immune-reconstitution-in-na-ve-hiv-patients-with-cd4-100-cells-ml-when-treated-with-lopinavir-or-efavirenz-134275https://curecurrent.com/trials/reducing-risk-and-trauma-related-stress-in-persons-living-with-hiv-134276https://curecurrent.com/trials/the-role-of-naive-t-cells-in-hiv-pathogenesis-134277https://curecurrent.com/trials/a-simplified-kaletra-lopinavir-ritonavir-based-therapy-versus-a-sustiva-efavirenz-based-standard-of-care-in-previously-n-134278https://curecurrent.com/trials/outcome-evaluation-of-minority-aids-initiative-programs-in-the-new-york-ema-134279https://curecurrent.com/trials/effect-study-of-a-theory-based-internet-intervention-on-safe-sex-practices-134280https://curecurrent.com/trials/high-dose-ritonavir-lopinavir-liquid-formulation-in-salvage-therapy-for-protease-inhibitor-resistant-hiv-disease-134281https://curecurrent.com/trials/pi-vs-nnrti-based-therapy-for-hiv-advanced-disease-134282https://curecurrent.com/trials/4-methylumbelliferone-as-a-treatment-for-chronic-hbv-hcv-134283https://curecurrent.com/trials/multicentric-trial-comparing-three-therapeutical-strategies-in-patients-with-acute-primary-hiv-infection-134284https://curecurrent.com/trials/now-thai-haart-study-134285https://curecurrent.com/trials/distant-healing-for-hiv-aids-134286https://curecurrent.com/trials/the-use-of-reiki-for-patients-with-advanced-aids-134287https://curecurrent.com/trials/alternative-stress-management-approaches-in-hiv-disease-134288https://curecurrent.com/trials/spirituality-and-will-to-live-in-patients-with-hiv-aids-134289https://curecurrent.com/trials/curb-alter-lower-or-manage-stress-in-hiv-calms-hiv-134290https://curecurrent.com/trials/relaxation-response-with-acupuncture-for-hiv-patients-134291https://curecurrent.com/trials/immune-restoration-by-lipoic-acid-in-aids-134292https://curecurrent.com/trials/dehydroepiandrosterone-effects-on-hiv-1-replication-134293https://curecurrent.com/trials/massage-to-increase-well-being-and-immune-function-in-dominican-children-infected-with-hiv-134294https://curecurrent.com/trials/a-study-of-two-different-doses-of-abt-378-ritonavir-in-hiv-infected-patients-who-have-taken-protease-inhibitors-and-non-134295https://curecurrent.com/trials/project-respect-the-efficacy-of-hiv-std-prevention-counseling-134296https://curecurrent.com/trials/a-randomized-controlled-trial-of-acyclovir-among-hiv-and-hsv-2-co-infected-women-chiang-rai-thailand-134297https://curecurrent.com/trials/problems-associated-with-the-use-of-anti-hiv-drugs-in-hiv-infected-pregnant-women-134298https://curecurrent.com/trials/study-of-tenofovir-disoproxil-fumarate-tdf-for-prevention-of-hiv-134299https://curecurrent.com/trials/a-safety-and-tolerability-study-of-dapivirine-tmc120-vaginal-microbicide-gel-134300https://curecurrent.com/trials/amprenavir-ritonavir-or-saquinavir-ritonavir-in-hiv-infected-subjects-following-failure-with-kaletra-as-their-second-pro-134301https://curecurrent.com/trials/effectiveness-of-abt-378-ritonavir-plus-lamivudine-plus-efavirenz-plus-tenofovir-df-in-hiv-infected-patients-134302https://curecurrent.com/trials/study-of-lopinavir-ritonavir-tenofovir-and-emtricitabine-in-hiv-infected-antiretroviral-na-ve-subjects-134303https://curecurrent.com/trials/a-study-exploring-an-induction-maintenance-kaletra-based-therapy-versus-a-sustiva-based-regimen-in-previously-non-treate-134304https://curecurrent.com/trials/basta-study-on-sti-in-hiv-infected-patients-134305https://curecurrent.com/trials/capravirine-to-treat-children-with-hiv-infection-134306https://curecurrent.com/trials/a-pilot-study-of-ltb4-in-hiv-1-infected-adults-134307https://curecurrent.com/trials/prophylactic-intrapartum-antibiotics-and-immunological-markers-for-postpartum-morbidity-in-hiv-positive-women-134308https://curecurrent.com/trials/pravastatin-for-hyperlipidaemia-in-hiv-134309https://curecurrent.com/trials/randomised-controlled-trial-assessing-the-impact-of-genital-herpes-suppressive-therapy-on-hiv-shedding-134310https://curecurrent.com/trials/a-study-to-assess-the-pharmacokinetics-of-dapivirine-tmc120-vaginal-microbicide-gel-134311https://curecurrent.com/trials/study-of-the-influence-of-vaccination-in-hiv-viral-load-and-immunologic-responses-against-hiv-134312https://curecurrent.com/trials/structured-treatment-interruptions-in-chronic-hiv-infection-134313https://curecurrent.com/trials/safety-and-tolerability-of-z-100-in-patients-with-early-hiv-infection-134314https://curecurrent.com/trials/mediclas-study-metabolic-effects-of-different-classes-of-antiretrovirals-134315https://curecurrent.com/trials/nevirapine-levels-and-fluconazole-134316https://curecurrent.com/trials/a-dose-response-and-safety-study-of-procaine-hcl-in-hiv-infected-patients-134317https://curecurrent.com/trials/proton-magnetic-resonance-spectroscopy-1h-mrs-in-evaluating-the-bone-marrow-muscle-and-adipose-tissue-on-normal-and-huma-134318https://curecurrent.com/trials/a-study-of-an-oral-entry-inhibitor-sp01a-in-treatment-experienced-hiv-infected-patients-134319https://curecurrent.com/trials/comparing-a-nucleoside-analogue-sparing-regimen-and-a-protease-inhibitor-sparing-regimen-in-hiv-infected-patients-134320https://curecurrent.com/trials/the-effect-of-efavirenz-and-nelfinavir-on-the-blood-levels-of-certain-lipid-lowering-drugs-134321https://curecurrent.com/trials/reducing-hiv-domestic-violence-risk-in-women-offenders-134322https://curecurrent.com/trials/directly-observed-therapy-in-high-risk-populations-in-newark-nj-134323https://curecurrent.com/trials/monotherapy-versus-placebo-over-7-days-non-nucleoside-reverse-transcriptase-inhibitor-experienced-hiv1-infected-adults-134324https://curecurrent.com/trials/interaction-between-hiv-and-lymphatic-filariasis-134325https://curecurrent.com/trials/study-of-tenofovir-disoproxil-fumarate-tdf-for-prevention-of-hiv-134326https://curecurrent.com/trials/safety-and-efficacy-study-of-prosaptide-to-treat-neuropathic-pain-in-hiv-positive-patients-134327https://curecurrent.com/trials/intermittent-preventive-treatment-of-malaria-in-hiv-seropositive-pregnant-women-in-zambia-134328https://curecurrent.com/trials/two-approaches-to-providing-hiv-aids-services-in-the-community-to-people-living-with-hiv-aids-134329https://curecurrent.com/trials/zidovudine-lamivudine-nevirapine-twice-daily-versus-tenofovir-lamivudine-nevirapine-once-daily-in-arv-naive-patients-134330https://curecurrent.com/trials/a-pilot-study-of-triple-ntrti-nsrti-therapy-in-antiretroviral-naive-hiv-1-infected-patients-134331https://curecurrent.com/trials/impact-of-cotrimoxazole-prophylaxis-for-hiv-infected-adults-on-antifolate-resistance-134332https://curecurrent.com/trials/a-comparison-of-lamivudine-and-zidovudine-used-alone-and-together-in-hiv-infected-patients-who-have-not-used-zidovudine-134333https://curecurrent.com/trials/safety-and-efficacy-of-zinc-supplementation-in-hiv-1-infected-children-in-south-africa-134334https://curecurrent.com/trials/imaging-trial-of-the-distribution-of-topical-gel-in-the-human-vagina-enhanced-mri-techniques-to-increase-resolution-134335https://curecurrent.com/trials/evaluation-of-the-occurrence-of-lipoatrophy-in-hiv-1-infected-naive-patients-134336https://curecurrent.com/trials/study-evaluating-the-impact-on-fat-distribution-of-nucleoside-reverse-transcriptase-inhibitor-nrti-sparing-regimens-in-a-134337https://curecurrent.com/trials/a-study-to-compare-three-doses-of-t-20-when-given-in-combination-with-abacavir-amprenavir-ritonavir-and-efavirenz-to-hiv-134338https://curecurrent.com/trials/study-of-hiv-1-rgp-160-administered-by-mucosal-routes-in-healthy-volunteers-134339https://curecurrent.com/trials/impact-of-hiv-on-measles-and-measles-immunisation-134340https://curecurrent.com/trials/once-daily-3tc-efavirenz-and-ddi-for-hiv-infection-134341https://curecurrent.com/trials/an-imaging-trial-of-the-distribution-of-topical-gel-in-the-human-vagina-assessment-of-bare-spots-134342https://curecurrent.com/trials/cohort-study-for-patients-using-fuzeon-enfuvirtide-134343https://curecurrent.com/trials/an-educational-hiv-pre-test-counseling-video-program-for-off-hours-testing-in-the-ed-a-randomized-control-trial-134344https://curecurrent.com/trials/hrn-004-peginterferon-a-2a-plus-ribavirin-for-chronic-hepatitis-c-infection-in-hiv-infected-persons-who-have-failed-to-a-134345https://curecurrent.com/trials/an-imaging-trial-of-the-distribution-of-topical-gel-formulations-in-the-human-vagina-134346https://curecurrent.com/trials/peg-interferon-a-2b-ribavirin-for-treatment-of-chronic-hrn-005-hepatitis-c-infection-in-hiv-infected-persons-not-previou-134347https://curecurrent.com/trials/evaluation-of-viral-efficacy-and-safety-of-a-reduced-dose-of-stavudine-d4t-the-phoenix-study-134348https://curecurrent.com/trials/integrating-buprenorphine-into-hiv-treatment-134349https://curecurrent.com/trials/an-effective-alternative-to-the-standard-referral-system-for-hiv-testing-in-the-emergency-department-during-off-hour-tou-134350https://curecurrent.com/trials/the-effects-of-a-supervised-exercise-program-on-self-efficacy-of-people-living-with-hiv-aids-134351https://curecurrent.com/trials/adolescent-impact-a-behavioral-intervention-for-adolescents-living-with-hiv-aids-134352https://curecurrent.com/trials/lopinavir-r-monotherapy-as-maintenance-therapy-after-long-term-viral-suppression-134353https://curecurrent.com/trials/effect-of-pioglitazone-on-hiv-1-related-lipoatrophy-a-randomized-double-blind-placebo-controlled-trial-in-130-patients-134354https://curecurrent.com/trials/trial-of-savvy-vaginal-gel-and-hiv-in-nigeria-134355https://curecurrent.com/trials/dose-ranging-trial-of-tipranavir-ritonavir-in-treatment-experienced-hiv-infected-individuals-134356https://curecurrent.com/trials/hiv-immune-and-virological-responses-following-the-administration-of-il-2-either-alone-or-combined-to-alvac-hiv-1433-and-134357https://curecurrent.com/trials/structured-treatment-interruption-for-hiv-patients-with-virologic-failure-134358https://curecurrent.com/trials/project-team-teaching-hiv-prevention-in-the-hiv-clinic-134359https://curecurrent.com/trials/tbtc-study-23a-pharmacokinetics-of-intermittent-isoniazid-and-rifabutin-in-hiv-tb-134360https://curecurrent.com/trials/tbtc-study-25pk-intensive-pharmacokinetic-study-of-three-doses-of-rifapentine-and-25-desacetyl-rifapentine-134361https://curecurrent.com/trials/trial-of-savvy-and-hiv-in-ghana-134362https://curecurrent.com/trials/tbtc-study-23b-intensive-pk-of-the-nelfinavir-rifabutin-interaction-in-patients-with-hiv-tb-134363https://curecurrent.com/trials/tbtc-study-23-treatment-of-hiv-related-tuberculosis-using-a-rifabutin-based-regimen-134364https://curecurrent.com/trials/switching-from-zidovudine-to-an-nnrti-or-lopinavir-ritonavir-in-patients-treated-with-zidovudine-lamivudine-abacavir-134365https://curecurrent.com/trials/in-vivo-response-of-p-falciparum-to-antimalarial-treatment-in-hiv-infected-and-hiv-uninfected-adults-134366https://curecurrent.com/trials/mother-infant-rapid-intervention-at-delivery-telephone-outreach-for-neonatal-therapy-tot-trial-134367https://curecurrent.com/trials/prevention-of-malaria-during-pregnancy-using-intermittent-preventive-treatment-with-sulfadoxine-pyrimethamine-malawi-134368https://curecurrent.com/trials/efficacy-of-rituximab-and-cyclophosphamide-doxorubicin-vincristine-prednisone-chop-in-patients-with-hiv-associated-non-h-134369https://curecurrent.com/trials/structured-treatment-interruptions-with-or-without-pegylated-interferon-alpha-for-hiv-infected-patients-after-prolonged-134370https://curecurrent.com/trials/intermittent-therapy-in-hiv-1-infected-patients-with-successful-viral-suppression-under-highly-active-antiretroviral-the-134371https://curecurrent.com/trials/evaluation-of-therapeutic-drug-monitoring-of-protease-inhibitors-on-virologic-success-and-tolerance-of-highly-active-ant-134372https://curecurrent.com/trials/peer-mentors-for-adolescents-in-hiv-affected-families-134373https://curecurrent.com/trials/efficacy-and-safety-of-tenofovir-df-atazanavir-enhanced-with-low-dose-of-ritonavir-in-hiv-infected-patients-134374https://curecurrent.com/trials/a-14-day-study-of-racivir-when-used-in-combination-in-hiv-infected-males-134375https://curecurrent.com/trials/a-study-of-dpc-817-in-hiv-infected-males-134376https://curecurrent.com/trials/treatment-of-acute-hiv-infection-to-preserve-immune-function-134377https://curecurrent.com/trials/phase-iii-ganciclovir-rgm-csf-for-aids-related-cmv-retinitis-134378https://curecurrent.com/trials/an-oral-dose-ranging-finding-study-in-patients-with-hiv-disease-cdc-classification-groups-iib-iii-and-iv-c2-134379https://curecurrent.com/trials/a-phase-i-trial-to-evaluate-the-safety-and-pharmacokinetics-of-1592u89-134380https://curecurrent.com/trials/the-effects-of-treatment-for-mycobacterium-avium-complex-mac-on-the-cells-of-hiv-infected-patients-134381https://curecurrent.com/trials/a-study-of-delavirdine-used-together-with-other-anti-hiv-drugs-in-hiv-infected-patients-134382https://curecurrent.com/trials/double-blind-study-of-timunox-thymopentin-in-asymptomatic-hiv-infected-patients-receiving-either-mono-azt-or-ddi-or-comb-134383https://curecurrent.com/trials/a-randomized-phase-iii-clinical-trial-of-daunoxome-versus-combination-chemotherapy-with-adriamycin-bleomycin-vincristine-134384https://curecurrent.com/trials/a-double-blind-placebo-controlled-study-with-open-label-follow-up-to-determine-the-safety-and-efficacy-of-r-huepo-in-aid-134385https://curecurrent.com/trials/a-study-of-efavirenz-in-hiv-infected-patients-who-have-never-taken-anti-hiv-drugs-134386https://curecurrent.com/trials/a-study-of-nystatin-in-hiv-infected-patients-134387https://curecurrent.com/trials/a-safety-pilot-pharmacokinetics-and-neurocognitive-study-of-as-101-in-combination-with-zidovudine-in-aids-arc-patients-134388https://curecurrent.com/trials/a-multi-center-randomized-double-blind-placebo-controlled-study-of-the-efficacy-and-safety-of-adefovir-dipivoxil-when-ad-134389https://curecurrent.com/trials/protocol-for-the-treatment-of-cryptosporidiosis-in-aids-patients-with-diclazuril-r64-433-134390https://curecurrent.com/trials/a-phase-ii-parallel-group-randomized-placebo-controlled-study-of-the-safety-and-efficacy-of-thalidomide-in-reducing-weig-134391https://curecurrent.com/trials/a-study-to-compare-two-anti-hiv-drug-combinations-that-include-amprenavir-in-hiv-infected-patients-who-have-failed-anti-134392https://curecurrent.com/trials/a-randomized-study-comparing-the-safety-and-efficacy-of-two-regimens-of-oral-ganciclovir-to-intravenous-ganciclovir-main-134393https://curecurrent.com/trials/a-study-to-compare-the-effects-of-two-anti-hiv-drug-combinations-on-the-immune-systems-of-hiv-infected-patients-134394https://curecurrent.com/trials/a-28-day-study-of-diclazuril-in-the-treatment-of-cryptosporidiosis-in-patients-with-aids-134395https://curecurrent.com/trials/a-study-of-rifabutin-used-alone-or-with-ethambutol-in-the-prevention-of-mycobacterium-avium-complex-mac-bacteremia-in-pa-134396https://curecurrent.com/trials/a-phase-i-study-of-three-doses-of-opc-8212-vesnarinone-in-hiv-infected-persons-with-cd4-cell-number-300-cells-mm3-134397https://curecurrent.com/trials/the-safety-and-effectiveness-of-cidofovir-in-the-treatment-of-cytomegalovirus-cmv-of-the-eyes-in-patients-with-aids-134398https://curecurrent.com/trials/a-study-to-compare-the-safety-and-effectiveness-of-indinavir-combined-with-stavudine-and-lamivudine-134399https://curecurrent.com/trials/effectiveness-of-treating-hiv-positive-patients-with-an-hiv-vaccine-remune-134400https://curecurrent.com/trials/a-study-of-the-effects-of-amprenavir-a-protease-inhibitor-on-carbohydrate-and-fat-metabolism-in-hiv-infected-patients-134401https://curecurrent.com/trials/hiv-candidate-vaccine-alvac-hiv-1-administration-in-hiv-negative-adults-134402https://curecurrent.com/trials/topical-use-of-4-4-dihydroxybenzophenone-2-4-dinitrophenylhydrazone-a-007-in-the-treatment-of-advanced-malignancies-incl-134403https://curecurrent.com/trials/multicenter-comparison-of-fluconazole-uk-49-858-and-amphotericin-b-as-treatment-for-acute-cryptococcal-meningitis-134404https://curecurrent.com/trials/safety-and-effectiveness-of-peg-intron-in-hiv-infected-patients-134405https://curecurrent.com/trials/an-open-label-multicenter-study-to-evaluate-the-safety-and-tolerability-of-dideoxycytidine-ddc-in-patients-with-aids-or-134406https://curecurrent.com/trials/safety-and-effectiveness-of-fluconazole-versus-sch-56592-to-treat-thrush-in-hiv-positive-patients-134407https://curecurrent.com/trials/a-study-of-two-methods-of-determining-when-to-begin-or-change-anti-hiv-treatment-134408https://curecurrent.com/trials/the-safety-and-effectiveness-of-retrovir-in-hiv-infected-patients-who-have-problems-related-to-the-nervous-system-134409https://curecurrent.com/trials/the-safety-and-effectiveness-of-two-forms-of-saquinavir-combined-with-other-anti-hiv-drugs-in-hiv-infected-infants-and-c-134410https://curecurrent.com/trials/a-study-of-pmpa-in-hiv-infected-patients-134411https://curecurrent.com/trials/a-phase-i-study-of-the-safety-and-pharmacokinetics-of-recombinant-cd4-immunoglobulin-g-rcd4-igg-in-infants-and-children-134412https://curecurrent.com/trials/a-study-of-nitazoxanide-in-the-treatment-of-aids-related-diarrhea-134413https://curecurrent.com/trials/safety-tolerance-efficacy-and-pharmacokinetics-of-multiple-doses-of-scd4-pe40-in-the-treatment-of-hiv-infected-individua-134414https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-azithromycin-in-individual-patients-with-serious-nontuberculous-mycobacte-134415https://curecurrent.com/trials/a-study-of-wf-10-iv-solution-in-patients-with-advanced-hiv-disease-134416https://curecurrent.com/trials/a-comparison-of-emtricitabine-and-stavudine-used-with-didanosine-plus-efavirenz-in-hiv-infected-patients-who-have-not-ta-134417https://curecurrent.com/trials/a-randomized-controlled-multicenter-trial-of-filgrastim-recombinant-methionyl-human-granulocyte-colony-stimulating-facto-134418https://curecurrent.com/trials/combination-treatment-using-capravirine-ag1549-nelfinavir-and-two-nucleoside-reverse-transcriptase-inhibitors-in-hiv-pat-134419https://curecurrent.com/trials/phase-i-trial-of-s-1153-in-patients-with-hiv-infection-134420https://curecurrent.com/trials/a-study-on-the-safety-and-effectiveness-of-l-756423-plus-indinavir-in-hiv-positive-patients-who-have-previously-taken-in-134421https://curecurrent.com/trials/double-blind-study-of-thymopentin-effects-on-hiv-1-infectivity-of-blood-mononuclear-cells-and-semen-in-hiv-infected-pati-134422https://curecurrent.com/trials/a-comparison-of-atovaquone-and-pentamidine-in-the-prevention-of-pneumocystis-carinii-pneumonia-in-hiv-infected-patients-134423https://curecurrent.com/trials/a-phase-i-ii-study-of-intralesional-recombinant-tumor-necrosis-factor-in-patients-with-aids-related-cutaneous-kaposi-s-s-134424https://curecurrent.com/trials/open-label-compassionate-use-study-of-spiramycin-for-the-treatment-of-diarrhea-due-to-chronic-cryptosporidiosis-in-immun-134425https://curecurrent.com/trials/trial-of-an-alternative-dosing-regimen-of-oral-retrovir-in-patients-with-aids-or-advanced-arc-134426https://curecurrent.com/trials/evaluation-of-the-epidermal-langerhans-cell-population-in-aids-arc-patients-by-the-topical-application-of-a-potent-conta-134427https://curecurrent.com/trials/safety-and-effectiveness-of-an-experimental-drug-im862-in-treating-kaposi-s-sarcoma-in-aids-patients-134428https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-anti-hiv-therapy-on-lean-tissue-muscle-in-hiv-positive-patients-134429https://curecurrent.com/trials/a-phase-i-study-to-evaluate-the-pharmacokinetics-safety-and-antiviral-effects-of-concurrent-administration-of-zidovudine-134430https://curecurrent.com/trials/a-long-term-follow-on-safety-study-of-four-doses-of-opc-8212-vesnarinone-in-hiv-infected-persons-134431https://curecurrent.com/trials/a-phase-i-ii-study-of-recombinant-human-gm-csf-in-patients-with-aids-virus-infection-and-leukopenia-134432https://curecurrent.com/trials/a-randomized-controlled-study-of-the-safety-and-preventive-efficacy-of-oral-ganciclovir-when-used-in-conjunction-with-an-134433https://curecurrent.com/trials/an-expanded-access-open-label-compassionate-use-protocol-of-remune-in-hiv-1-infected-adults-with-cd4-count-less-than-300-134434https://curecurrent.com/trials/azithromycin-in-the-treatment-of-cryptosporidiosis-in-patients-with-acquired-immune-deficiency-syndrome-aids-a-randomize-134435https://curecurrent.com/trials/a-randomized-parallel-arm-comparative-open-label-multicenter-study-of-the-activity-and-safety-of-two-formulations-of-saq-134436https://curecurrent.com/trials/ganciclovir-compassionate-use-in-patients-with-serious-or-life-threatening-cytomegalovirus-infections-134437https://curecurrent.com/trials/a-randomized-controlled-prophylactic-study-of-clofazimine-to-prevent-mycobacterium-avium-complex-infection-in-hiv-diseas-134438https://curecurrent.com/trials/an-open-label-uncontrolled-clinical-trial-of-oral-566c80-for-the-treatment-of-patients-with-severe-pcp-who-are-intoleran-134439https://curecurrent.com/trials/phase-ii-placebo-controlled-study-of-thalidomide-in-patients-with-mycobacterial-and-hiv-infections-134440https://curecurrent.com/trials/the-effectiveness-of-hiv-rna-viral-load-testing-in-determining-treatment-type-in-hiv-infected-patients-134441https://curecurrent.com/trials/comparative-randomized-study-of-the-efficacy-safety-and-toleration-of-fluconazole-oral-suspension-or-nystatin-oral-suspe-134442https://curecurrent.com/trials/a-study-of-foscarnet-in-the-treatment-of-cytomegalovirus-cmv-of-the-eyes-in-patients-with-aids-who-have-not-had-success-134443https://curecurrent.com/trials/a-comparison-of-fluconazole-and-amphotericin-b-in-the-treatment-of-fungal-infections-134444https://curecurrent.com/trials/the-effects-of-thymopentin-on-hiv-infectivity-of-blood-cells-and-semen-in-hiv-infected-patients-134445https://curecurrent.com/trials/a-pilot-study-of-the-efficacy-of-recombinant-alpha-interferon-ifn-a2b-and-zidovudine-azt-in-the-treatment-of-progressive-134446https://curecurrent.com/trials/the-safety-and-effectiveness-of-1592u89-plus-141w94-plus-dmp-266-in-patients-with-hiv-who-developed-a-resistance-to-prot-134447https://curecurrent.com/trials/a-study-of-thioctic-acid-and-deprenyl-in-hiv-infected-patients-with-dementia-134448https://curecurrent.com/trials/safety-and-effectiveness-of-adding-adefovir-dipivoxil-and-nelfinavir-to-the-anti-hiv-therapy-of-hiv-infected-children-134449https://curecurrent.com/trials/a-study-of-amprenavir-in-patients-with-protease-inhibitor-related-complications-134450https://curecurrent.com/trials/treatment-with-nelfinavir-or-efavirenz-of-hiv-infected-patients-who-have-never-received-anti-hiv-drugs-134451https://curecurrent.com/trials/photodynamic-therapy-clinical-trial-for-cutaneous-aids-related-kaposi-s-sarcoma-study-summary-134452https://curecurrent.com/trials/a-compassionate-treatment-protocol-for-the-use-of-trimetrexate-glucuronate-with-leucovorin-protection-for-patients-with-134453https://curecurrent.com/trials/a-study-of-targretin-capsules-in-patients-with-aids-related-kaposi-s-sarcoma-134454https://curecurrent.com/trials/a-study-of-retrovir-and-epivir-alone-or-in-combination-with-141w94-in-hiv-infected-patients-134455https://curecurrent.com/trials/an-open-multicenter-randomized-dose-ranging-study-of-azithromycin-in-the-treatment-of-disseminated-mycobacterium-avium-i-134456https://curecurrent.com/trials/differences-between-women-and-men-taking-a-combination-of-indinavir-ritonavir-enteric-coated-didanosine-and-stavudine-wh-134457https://curecurrent.com/trials/hiv-symptom-management-program-for-african-american-mothers-134458https://curecurrent.com/trials/phase-ii-iii-study-of-the-tolerance-and-efficacy-of-combined-use-of-didanosine-2-3-dideoxyinosine-ddi-and-lentinan-in-hi-134459https://curecurrent.com/trials/a-study-of-1592u89-in-hiv-infected-adults-134460https://curecurrent.com/trials/phase-ii-study-of-novantrone-r-mitoxantrone-and-etoposide-in-patients-with-hiv-associated-large-cell-and-immunoblastic-l-134461https://curecurrent.com/trials/safety-and-effectiveness-of-an-anti-hiv-drug-combination-in-hiv-positive-patients-who-have-failed-previous-treatment-wit-134462https://curecurrent.com/trials/the-safety-and-effectiveness-of-adefovir-dipivoxil-plus-indinavir-combined-with-zidovudine-or-lamivudine-or-stavudine-in-134463https://curecurrent.com/trials/comparison-of-two-dosing-regimens-of-gw433908-ritonavir-versus-lopinavir-ritonavir-for-48-weeks-in-hiv-patients-who-have-134464https://curecurrent.com/trials/safety-and-effectiveness-of-combining-hydroxyurea-hu-with-didanosine-ddi-and-stavudine-d4t-for-treatment-of-hiv-infected-134465https://curecurrent.com/trials/an-hiv-vaccine-preparedness-study-134466https://curecurrent.com/trials/a-study-of-isoprinosine-in-patients-with-lymph-node-disease-134467https://curecurrent.com/trials/the-safety-and-effectiveness-of-nevirapine-plus-lamivudine-plus-other-anti-hiv-drugs-134468https://curecurrent.com/trials/treatment-and-suppression-of-hairy-leukoplakia-in-arc-patients-with-oral-acyclovir-acv-134469https://curecurrent.com/trials/valganciclovir-in-patients-with-cmv-retinitis-and-aids-who-cannot-take-drugs-by-injection-134470https://curecurrent.com/trials/the-safety-and-effectiveness-of-three-anti-hiv-drug-combinations-in-hiv-infected-patients-who-have-taken-azt-134471https://curecurrent.com/trials/a-multicenter-double-blind-phase-iii-adjuvant-controlled-study-of-the-effect-of-10-units-of-hiv-1-immunogen-remune-compa-134472https://curecurrent.com/trials/the-effectiveness-of-indinavir-plus-zidovudine-plus-lamivudine-in-hiv-infected-patients-with-no-symptoms-of-infection-134473https://curecurrent.com/trials/a-phase-i-pharmacokinetic-study-in-hiv-positive-subjects-of-oral-ganciclovir-and-concomitant-antiretroviral-zidovudine-a-134474https://curecurrent.com/trials/a-study-of-ddc-in-patients-with-aids-or-advanced-aids-related-complex-arc-who-have-not-had-success-with-zidovudine-azt-134475https://curecurrent.com/trials/a-study-of-fluconazole-in-the-treatment-of-fungal-infections-of-the-throat-in-patients-with-weakened-immune-systems-134476https://curecurrent.com/trials/a-study-of-fluconazole-in-the-treatment-of-cryptococcal-meningitis-in-patients-with-aids-134477https://curecurrent.com/trials/the-safety-and-effectiveness-of-saquinavir-soft-gelatin-capsules-combined-with-other-anti-hiv-drugs-134478https://curecurrent.com/trials/a-randomized-double-blind-comparative-study-of-azithromycin-versus-clarithromycin-in-combination-with-ethambutol-for-the-134479https://curecurrent.com/trials/the-pilot-study-of-foscarnet-cream-in-the-treatment-of-mucocutaneous-herpes-simplex-virus-infections-in-immunocompromise-134480https://curecurrent.com/trials/a-study-of-saquinavir-and-zalcitabine-used-alone-and-together-in-the-treatment-of-advanced-hiv-infection-in-patients-who-134481https://curecurrent.com/trials/a-study-of-azithromycin-in-hiv-infected-patients-134482https://curecurrent.com/trials/a-study-to-find-the-best-dosing-schedule-for-delavirdine-zidovudine-and-indinavir-in-hiv-positive-patients-134483https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-cimetidine-on-cd4-lymphocyte-counts-in-hiv-infection-134484https://curecurrent.com/trials/an-open-study-of-foscarnet-treatment-first-episode-cmv-retinitis-in-aids-patients-134485https://curecurrent.com/trials/a-comparison-of-saquinavir-hard-and-soft-gelatin-capsules-in-hiv-infected-patients-134486https://curecurrent.com/trials/a-double-blind-randomized-clinical-trial-of-a-rifabutin-regimen-in-the-treatment-of-mycobacterium-avium-complex-mac-bact-134487https://curecurrent.com/trials/safety-and-effectiveness-of-giving-an-anti-hiv-drug-combination-of-adefovir-dipivoxil-plus-didanosine-plus-efavirenz-plu-134488https://curecurrent.com/trials/a-study-of-viracept-in-aids-patients-with-cytomegalovirus-retinitis-134489https://curecurrent.com/trials/a-phase-i-ii-trial-to-assess-the-safety-and-tolerance-of-escalating-doses-of-a-human-anti-cytomegalovirus-monoclonal-ant-134490https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-chronically-administered-mdl-28-574a-in-the-treatment-of-hiv-infected-patients-134491https://curecurrent.com/trials/the-metabolic-effects-of-protease-inhibitors-in-hiv-infected-children-134492https://curecurrent.com/trials/a-phase-i-study-of-subcutaneously-administered-proleukin-aldesleukin-in-hiv-infected-patients-134493https://curecurrent.com/trials/a-three-arm-comparative-trial-for-the-treatment-of-mac-bacteremia-in-aids-a-clarithromycin-ethambutol-regimen-containing-134494https://curecurrent.com/trials/a-comparison-of-dapsone-and-trimethoprim-sulfamethoxazole-in-the-treatment-of-pneumocystis-carinii-pneumonia-pcp-in-pati-134495https://curecurrent.com/trials/a-dose-frequency-trial-of-oral-retrovir-in-patients-with-aids-or-severe-arc-134496https://curecurrent.com/trials/safety-and-effectiveness-of-giving-combinations-of-three-or-four-anti-hiv-drugs-to-hiv-infected-patients-134497https://curecurrent.com/trials/a-phase-i-multicenter-study-of-the-safety-and-immunogenicity-of-mn-rgp120-hiv-1-vaccine-given-either-alone-or-in-combina-134498https://curecurrent.com/trials/the-safety-and-effectiveness-of-nevirapine-and-zidovudine-given-separately-and-together-in-hiv-1-infected-patients-who-h-134499https://curecurrent.com/trials/a-rollover-study-to-provide-chronic-t-1249-to-patients-who-completed-study-t1249-102-134500https://curecurrent.com/trials/a-study-to-compare-the-effectiveness-of-two-anti-hiv-drug-combinations-134501https://curecurrent.com/trials/safety-and-effectiveness-of-3-anti-hiv-treatments-in-patients-who-have-failed-previous-treatments-containing-nelfinavir-134502https://curecurrent.com/trials/effectiveness-of-an-hiv-vaccine-in-hiv-negative-adults-in-north-america-who-are-at-risk-of-hiv-infection-134503https://curecurrent.com/trials/phase-ii-study-of-the-safety-and-surrogate-marker-efficacy-of-butyldeoxynojirimycin-sc-48334-and-azt-in-symptomatic-hiv-134504https://curecurrent.com/trials/a-multicenter-exploratory-study-to-evaluate-the-effects-of-antiretroviral-cessation-on-plasma-associated-hiv-1-rna-134505https://curecurrent.com/trials/a-study-to-see-whether-two-hiv-vaccines-are-safe-and-can-prevent-hiv-infection-134506https://curecurrent.com/trials/a-study-of-saquinavir-soft-gel-capsules-sgc-used-in-combination-with-two-other-anti-hiv-drugs-in-patients-with-hiv-assoc-134507https://curecurrent.com/trials/3tc-lamivudine-gr109714x-open-label-program-134508https://curecurrent.com/trials/a-comparison-of-isis-2922-used-immediately-or-later-in-patients-with-cytomegalovirus-cmv-of-the-eyes-134509https://curecurrent.com/trials/a-study-to-evaluate-the-impact-of-stopping-treatment-for-the-prevention-of-pneumonia-in-hiv-positive-patients-receiving-134510https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-study-of-l-leucovorin-in-combination-with-trimethoprim-sulfamethoxazole-in-134511https://curecurrent.com/trials/phase-i-study-of-the-safety-tolerance-and-pharmacokinetics-of-9-2-bispivaloyloxymethyl-phosphonylmethoxyethyl-adenine-bi-134512https://curecurrent.com/trials/a-phase-i-study-of-the-safety-and-pharmacokinetics-of-recombinant-human-cd4-immunoglobulin-rcd4-igg-administered-by-intr-134513https://curecurrent.com/trials/double-blind-randomized-placebo-controlled-study-of-low-dose-oral-interferon-alfa-n3-human-leukocyte-derived-in-arc-pati-134514https://curecurrent.com/trials/a-multiple-dose-crossover-pharmacokinetics-study-to-evaluate-the-effects-of-food-on-the-absorption-of-oral-ganciclovir-134515https://curecurrent.com/trials/a-pilot-study-of-opc-8212-vesnarinone-in-persons-with-aids-related-kaposi-s-sarcoma-134516https://curecurrent.com/trials/intranasal-peptide-t-in-the-treatment-of-painful-peripheral-neuropathy-of-aids-134517https://curecurrent.com/trials/a-phase-i-study-of-recombinant-human-cd4-immunoglobulin-g-rcd4-lgg-in-patients-with-hiv-associated-immune-thrombocytopen-134518https://curecurrent.com/trials/a-study-of-letrazuril-in-the-treatment-of-aids-related-diarrhea-134519https://curecurrent.com/trials/a-multicenter-open-label-randomized-24-week-study-to-compare-the-safety-and-activity-of-indinavir-sulfate-800-mg-q-8-h-v-134520https://curecurrent.com/trials/a-study-of-megestrol-acetate-in-hiv-infected-children-134521https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-trial-of-ubi-hiv-lipopeptide-vaccine-component-p3c541b-in-hiv-1-seronegative-human-s-134522https://curecurrent.com/trials/a-study-of-ganciclovir-in-the-treatment-of-cytomegalovirus-of-the-large-intestine-in-patients-with-aids-134523https://curecurrent.com/trials/a-randomized-comparison-of-intravitreal-isis-2922-plus-ganciclovir-versus-ganciclovir-as-treatment-for-patients-with-cyt-134524https://curecurrent.com/trials/a-study-of-141w94-in-combination-with-other-anti-hiv-drugs-134525https://curecurrent.com/trials/phase-i-ii-study-of-the-tolerance-and-efficacy-of-combined-use-of-didanosine-2-3-dideoxyinosine-ddi-and-lentinan-in-hiv-134526https://curecurrent.com/trials/a-study-to-compare-two-anti-hiv-drug-combinations-134527https://curecurrent.com/trials/a-phase-i-ii-study-of-the-safety-tolerance-and-pharmacokinetics-of-9-2-phosphonylmethoxyethyl-adenine-pmea-adefovir-in-p-134528https://curecurrent.com/trials/a-pilot-study-to-obtain-preliminary-information-regarding-the-efficacy-and-safety-of-the-combination-of-immune-globulin-134529https://curecurrent.com/trials/a-study-on-the-safety-and-effectiveness-of-adefovir-dipivoxil-in-combination-with-anti-hiv-therapy-haart-in-hiv-positive-134530https://curecurrent.com/trials/open-non-comparative-study-of-fluconazole-in-patients-with-coccidioidal-meningitis-134531https://curecurrent.com/trials/an-evaluation-of-pentoxifylline-in-hiv-positive-persons-with-symptomatic-hiv-infection-and-a-karnofsky-score-40-percent-134532https://curecurrent.com/trials/a-multi-center-randomized-double-blind-placebo-controlled-study-to-investigate-the-effect-of-isoprinosine-in-patients-wi-134533https://curecurrent.com/trials/the-safety-and-effectiveness-of-calanolide-a-in-hiv-infected-patients-who-have-never-taken-anti-hiv-drugs-134534https://curecurrent.com/trials/a-comparison-of-two-multi-drug-therapies-in-hiv-infected-patients-who-have-never-received-anti-hiv-treatment-134535https://curecurrent.com/trials/a-study-of-1592u89-and-ethanol-when-given-together-to-hiv-infected-patients-134536https://curecurrent.com/trials/tenofovir-disoproxil-fumarate-in-hiv-infected-patients-who-have-not-had-success-with-other-anti-hiv-drug-combinations-134537https://curecurrent.com/trials/the-effects-of-r-methuifn-gamma-on-the-lungs-of-patients-with-aids-134538https://curecurrent.com/trials/a-study-of-ro-24-7429-in-patients-with-hiv-related-kaposi-s-sarcoma-134539https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-trial-of-ubi-hiv-lipopeptide-immunotherapeutic-p3c541b-in-hiv-1-seropositive-human-s-134540https://curecurrent.com/trials/the-safety-and-effectiveness-of-cidofovir-in-the-treatment-of-venereal-warts-in-hiv-infected-patients-134541https://curecurrent.com/trials/a-comparative-trial-of-valacyclovir-hydrochloride-256u87-and-acyclovir-for-the-suppression-of-anogenital-herpes-infectio-134542https://curecurrent.com/trials/a-third-party-blinded-placebo-controlled-comparative-study-of-as-101-administered-intravenously-in-hiv-positive-patients-134543https://curecurrent.com/trials/a-phase-i-ii-study-of-the-safety-and-efficacy-of-topical-1-s-3-hydroxy-2-phosphonylmethoxypropyl-cytosine-dihydrate-cido-134544https://curecurrent.com/trials/a-pilot-study-of-fluconazole-plus-flucytosine-for-the-treatment-of-aids-patients-with-acute-cryptococcal-meningitis-134545https://curecurrent.com/trials/the-safety-and-effectiveness-of-different-dose-levels-of-1263w94-in-the-treatment-of-cytomegalovirus-cmv-of-the-eyes-in-134546https://curecurrent.com/trials/rosiglitazone-and-exercise-training-effects-on-hiv-infected-people-with-insulin-resistance-hypertriglyceridemia-and-adip-134547https://curecurrent.com/trials/a-study-of-dtc-in-patients-with-aids-and-aids-related-complex-134548https://curecurrent.com/trials/randomized-comparative-trial-of-dox-sl-stealth-liposomal-doxorubicin-hydrochloride-versus-bleomycin-and-vincristine-in-t-134549https://curecurrent.com/trials/treatment-program-for-anemia-in-aids-patients-134550https://curecurrent.com/trials/a-double-blind-placebo-controlled-study-with-open-label-follow-up-to-determine-the-safety-and-efficacy-of-r-huepo-in-aid-134551https://curecurrent.com/trials/a-double-blind-placebo-controlled-group-comparative-study-to-evaluate-the-safety-and-effectiveness-of-aerosol-pentamidin-134552https://curecurrent.com/trials/a-randomized-controlled-study-of-the-efficacy-and-safety-of-maintenance-treatment-with-oral-ganciclovir-for-newly-diagno-134553https://curecurrent.com/trials/an-open-label-safety-study-of-oral-ganciclovir-maintenance-treatment-of-cmv-retinitis-in-people-with-limited-venous-acce-134554https://curecurrent.com/trials/a-study-of-a-combination-of-four-drugs-in-patients-with-recent-hiv-infection-134555https://curecurrent.com/trials/a-study-of-fluconazole-in-the-prevention-of-fungal-infections-in-hiv-infected-patients-living-in-areas-where-fungal-infe-134556https://curecurrent.com/trials/use-of-stealth-liposomal-doxorubicin-hcl-dox-sl-in-the-treatment-of-moderate-to-severe-aids-related-kaposi-s-sarcoma-134557https://curecurrent.com/trials/a-phase-i-trial-of-tecogalan-sodium-ds-4152-administered-as-an-infusion-twice-weekly-for-21-days-134558https://curecurrent.com/trials/a-multicenter-placebo-controlled-dose-titration-study-to-evaluate-the-efficacy-and-safety-of-sandostatin-sms-201-995-in-134559https://curecurrent.com/trials/safety-and-effectiveness-of-three-anti-hiv-drugs-combined-in-one-pill-trizivir-134560https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-trial-of-ubi-microparticulate-monovalent-hiv-1-mn-peptide-immunogen-in-hiv-1-seroneg-134561https://curecurrent.com/trials/non-comparative-study-of-fluconazole-in-patients-with-serious-mycoses-and-who-cannot-be-treated-with-conventional-antifu-134562https://curecurrent.com/trials/a-randomized-double-blind-study-of-the-efficacy-and-safety-of-oral-ganciclovir-for-the-prevention-of-cmv-disease-in-peop-134563https://curecurrent.com/trials/randomized-controlled-double-blind-study-of-itraconazole-oral-solution-versus-fluconazole-tablets-for-the-treatment-of-e-134564https://curecurrent.com/trials/safety-and-effectiveness-of-the-drug-dpc-083-in-combination-with-nucleoside-analogue-reverse-transcriptase-inhibitors-in-134565https://curecurrent.com/trials/safety-and-effectiveness-of-lamivudine-when-given-once-a-day-versus-twice-a-day-in-combination-with-other-anti-hiv-drugs-134566https://curecurrent.com/trials/placebo-controlled-trial-of-safety-and-efficacy-of-thalidomide-in-patients-with-infections-due-to-mycobacterium-and-or-h-134567https://curecurrent.com/trials/a-comparison-of-fluconazole-and-ketoconazole-in-the-treatment-of-fungal-infections-of-the-throat-in-patients-with-weaken-134568https://curecurrent.com/trials/a-study-of-thymopentin-effects-on-hiv-1-infectivity-of-blood-mononuclear-cells-and-semen-in-hiv-infected-patients-134569https://curecurrent.com/trials/the-safety-and-effectiveness-of-indinavir-plus-ritonavir-plus-two-nrtis-in-hiv-infected-patients-who-need-early-interven-134570https://curecurrent.com/trials/the-effects-of-azt-and-ibuprofen-on-hiv-infected-patients-with-hemophilia-134571https://curecurrent.com/trials/the-safety-and-effectiveness-of-zidovudine-plus-lamivudine-used-with-and-without-1592u89-in-hiv-1-infected-children-who-134572https://curecurrent.com/trials/safety-and-effectiveness-of-giving-cpi-1189-to-hiv-infected-patients-with-aids-dementia-134573https://curecurrent.com/trials/parallel-group-placebo-controlled-tolerability-safety-and-efficacy-study-of-opc-14117-in-hiv-dementia-134574https://curecurrent.com/trials/a-phase-iii-randomized-double-blind-multicentre-study-to-evaluate-the-safety-and-efficacy-of-1592u89-in-patients-with-ai-134575https://curecurrent.com/trials/a-study-of-zidovudine-azt-used-alone-or-in-combination-with-other-anti-hiv-drugs-in-hiv-infected-patients-with-little-or-134576https://curecurrent.com/trials/education-program-to-promote-female-condom-use-134577https://curecurrent.com/trials/a-study-of-adefovir-dipivoxil-in-hiv-infected-patients-who-have-not-been-treated-with-anti-hiv-drugs-134578https://curecurrent.com/trials/an-ascending-single-oral-dose-pharmacokinetic-study-of-3-deoxy-3-fluorothymidine-flt-in-asymptomatic-human-immunodeficie-134579https://curecurrent.com/trials/a-study-of-granulocyte-colony-stimulating-factor-plus-recombinant-erythropoietin-plus-zidovudine-in-patients-with-aids-o-134580https://curecurrent.com/trials/a-dose-escalating-study-of-ro-31-8959-hiv-protease-inhibitor-in-patients-with-hiv-disease-134581https://curecurrent.com/trials/safety-and-effectiveness-of-giving-adefovir-dipivoxil-plus-abacavir-plus-efavirenz-plus-amprenavir-to-hiv-infected-patie-134582https://curecurrent.com/trials/the-safety-and-effectiveness-of-ribavirin-in-the-early-stages-of-hiv-infection-134583https://curecurrent.com/trials/study-of-perinatal-transmission-of-zidovudine-resistant-hiv-among-pregnant-women-treated-with-zidovudine-134584https://curecurrent.com/trials/a-study-of-azithromycin-in-the-prevention-of-mycobacterium-avium-complex-disease-mac-in-hiv-infected-patients-134585https://curecurrent.com/trials/randomized-phase-i-study-of-trimetrexate-glucuronate-tmtx-with-leucovorin-lcv-protection-plus-dapsone-versus-trimethopri-134586https://curecurrent.com/trials/a-study-of-trimetrexate-plus-leucovorin-in-children-with-pneumocystis-carinii-pneumonia-134587https://curecurrent.com/trials/phase-ii-study-of-intravenous-novantrone-r-in-the-treatment-of-aids-related-kaposi-s-sarcoma-134588https://curecurrent.com/trials/a-study-of-treatments-for-fungal-infections-of-the-mouth-and-throat-in-hiv-infected-patients-who-have-had-success-with-i-134589https://curecurrent.com/trials/a-controlled-trial-comparing-the-efficacy-of-aerosolized-pentamidine-and-parenteral-oral-trimethoprim-sulfamethoxazole-i-134590https://curecurrent.com/trials/a-study-of-different-doses-of-atevirdine-mesylate-plus-zidovudine-in-hiv-positive-patients-134591https://curecurrent.com/trials/ritonavir-and-agenerase-treatment-for-patients-who-have-failed-previous-anti-hiv-treatment-134592https://curecurrent.com/trials/a-study-of-three-different-anti-hiv-drug-combinations-in-hiv-infected-patients-134593https://curecurrent.com/trials/the-antiviral-efficacy-of-concurrent-zidovudine-and-2-3-dideoxyinosine-or-2-3-dideoxycytidine-in-patients-with-human-imm-134594https://curecurrent.com/trials/a-study-of-l-735-524-in-hiv-positive-children-and-adolescents-134595https://curecurrent.com/trials/a-randomized-trial-to-evaluate-the-safety-and-efficacy-of-combination-therapy-with-retrovir-azt-and-hivid-ddc-versus-ret-134596https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-combination-anti-hiv-therapy-in-hiv-infected-adults-134597https://curecurrent.com/trials/a-pilot-open-label-phase-ii-randomized-study-to-determine-the-effects-of-viracept-on-the-outcome-of-cutaneous-and-mucosa-134598https://curecurrent.com/trials/a-six-month-safety-and-antiviral-study-in-hiv-1-seropositive-azt-experienced-patients-with-cd4-counts-less-than-or-equal-134599https://curecurrent.com/trials/treatment-of-psoriasis-using-acitretin-in-hiv-positive-patients-134600https://curecurrent.com/trials/a-phase-i-study-of-the-safety-of-proleukin-aldesleukin-in-combination-with-ganciclovir-and-antiretroviral-therapy-in-hiv-134601https://curecurrent.com/trials/viracept-expanded-access-program-134602https://curecurrent.com/trials/open-label-ganciclovir-therapy-for-sight-or-life-threatening-cytomegalovirus-disease-in-the-immunocompromised-patient-134603https://curecurrent.com/trials/a-pre-enrollment-protocol-for-hiv-infected-adolescents-134604https://curecurrent.com/trials/a-study-of-zidovudine-and-t-lymphocyte-transfer-in-the-treatment-of-hiv-type-iii-in-patients-with-aids-134605https://curecurrent.com/trials/a-phase-i-randomized-dose-formulation-comparison-study-of-sc-52151-134606https://curecurrent.com/trials/t-20-in-hiv-patients-with-prior-drug-treatment-and-or-resistance-to-each-of-the-three-classes-of-anti-hiv-drugs-134607https://curecurrent.com/trials/the-safety-and-effectiveness-of-r-huepo-in-patients-with-aids-or-advanced-aids-related-complex-arc-who-are-anemic-134608https://curecurrent.com/trials/intensive-pharmacokinetics-of-the-nelfinavir-rifabutin-interaction-in-patients-with-hiv-related-tuberculosis-treated-wit-134609https://curecurrent.com/trials/phase-iii-randomized-double-blind-placebo-controlled-study-to-evaluate-the-safety-and-efficacy-of-betaseron-in-aids-and-134610https://curecurrent.com/trials/a-pilot-study-of-566c80-for-the-salvage-treatment-of-toxoplasmic-encephalitis-in-patients-infected-with-the-human-immuno-134611https://curecurrent.com/trials/a-multicenter-phase-ii-iii-placebo-controlled-study-of-snx-111-administered-intrathecally-to-cancer-and-aids-patients-wi-134612https://curecurrent.com/trials/the-safety-and-effectiveness-of-zidovudine-plus-adefovir-in-hiv-infected-patients-134613https://curecurrent.com/trials/a-study-of-capravirine-plus-viracept-plus-two-nucleoside-reverse-transcriptase-inhibitors-in-hiv-infected-patients-who-f-134614https://curecurrent.com/trials/a-phase-i-study-of-the-safety-and-pharmacokinetics-of-recombinant-cd4-rcd4-in-infants-and-children-infected-with-or-at-r-134615https://curecurrent.com/trials/a-study-of-viracept-in-hiv-positive-women-134616https://curecurrent.com/trials/comparing-ftc-and-lamivudine-in-hiv-infected-patients-on-a-stable-anti-hiv-drug-combination-134617https://curecurrent.com/trials/safety-and-effectiveness-of-l2-7001-interleukin-2-in-hiv-positive-patients-receiving-anti-hiv-therapy-134618https://curecurrent.com/trials/phase-i-study-of-safety-tolerability-and-pharmacokinetics-of-viracept-in-hiv-1-infected-children-and-exposed-infants-134619https://curecurrent.com/trials/the-effectiveness-of-cow-s-milk-immune-globulin-in-the-treatment-of-aids-related-diarrhea-134620https://curecurrent.com/trials/initial-phase-ii-efficacy-and-safety-study-of-sc-48334-administered-in-combination-with-low-dose-zidovudine-azt-to-sympt-134621https://curecurrent.com/trials/a-pilot-study-of-allogeneic-lymphocyte-transfer-in-hiv-infection-134622https://curecurrent.com/trials/a-phase-iiib-open-label-comparative-study-to-evaluate-saquinavir-soft-gel-capsule-sgc-treatment-in-combination-with-othe-134623https://curecurrent.com/trials/the-safety-and-effectiveness-of-524w91-134624https://curecurrent.com/trials/a-pilot-trial-evaluating-an-alternating-schedule-of-recombinant-human-gm-csf-and-azidothymidine-in-patients-with-hiv-inf-134625https://curecurrent.com/trials/a-study-of-foscarnet-in-the-treatment-of-cytomegalovirus-cmv-of-the-eyes-in-patients-with-aids-134626https://curecurrent.com/trials/a-study-of-two-anti-hiv-drug-combinations-in-hiv-infected-patients-134627https://curecurrent.com/trials/a-pilot-study-to-evaluate-the-effect-of-retrovir-zidovudine-azt-in-the-treatment-of-human-immunodeficiency-virus-hiv-ass-134628https://curecurrent.com/trials/sch-39304-as-therapy-for-acute-cryptococcal-meningitis-in-hiv-infected-patients-followed-by-maintenance-therapy-134629https://curecurrent.com/trials/cidofovir-as-a-treatment-for-herpes-simplex-in-patients-with-aids-134630https://curecurrent.com/trials/t-20-with-anti-hiv-combination-therapy-for-patients-with-prior-anti-hiv-drug-treatment-and-or-drug-resistance-to-each-of-134631https://curecurrent.com/trials/safety-and-effectiveness-of-giving-indinavir-ritonavir-stavudine-and-lamivudine-to-hiv-infected-patients-who-have-never-134632https://curecurrent.com/trials/computer-assisted-adherence-program-for-patients-taking-anti-hiv-drugs-134633https://curecurrent.com/trials/a-study-of-thalidomide-in-hiv-infected-patients-who-are-receiving-haart-134634https://curecurrent.com/trials/rifabutin-therapy-for-the-prevention-of-mycobacterium-avium-complex-mac-bacteremia-in-aids-patients-with-cd4-counts-or-2-134635https://curecurrent.com/trials/an-open-study-of-foscarnet-treatment-of-acyclovir-resistant-herpes-simplex-virus-in-patients-with-the-acquired-immunodef-134636https://curecurrent.com/trials/a-study-of-azidothymidine-azt-in-the-treatment-of-hiv-infection-in-patients-receiving-a-bone-marrow-transplant-134637https://curecurrent.com/trials/a-phase-ii-stratified-randomized-double-blind-multi-center-study-of-the-safety-and-efficacy-of-adefovir-dipivoxil-adf-at-134638https://curecurrent.com/trials/a-comparison-of-dox-sl-versus-adriamycin-plus-bleomycin-plus-vincristine-in-the-treatment-of-severe-aids-related-kaposi-134639https://curecurrent.com/trials/neurodevelopmental-and-neurological-study-of-infants-and-children-with-hiv-1-infection-and-aids-in-clinical-trials-134640https://curecurrent.com/trials/a-study-of-delavirdine-mesylate-in-combination-with-other-anti-hiv-drugs-in-hiv-infected-children-and-babies-134641https://curecurrent.com/trials/study-of-women-who-have-aids-134642https://curecurrent.com/trials/a-phase-i-ii-clinical-study-of-nystatin-i-v-intravenous-in-patients-with-hiv-infection-134643https://curecurrent.com/trials/a-study-of-cidofovir-in-the-treatment-of-cytomegalovirus-cmv-of-the-eyes-in-patients-with-aids-134644https://curecurrent.com/trials/the-safety-and-effectiveness-of-isoprinosine-in-patients-with-weakened-immune-systems-and-lymph-node-disease-134645https://curecurrent.com/trials/effectiveness-of-aids-antibody-screening-134646https://curecurrent.com/trials/a-double-blind-placebo-controlled-study-with-open-label-follow-up-to-determine-the-safety-and-efficacy-of-subcutaneous-d-134647https://curecurrent.com/trials/a-randomized-placebo-controlled-study-of-the-safety-and-efficacy-of-efavirenz-didanosine-and-stavudine-in-combination-wi-134648https://curecurrent.com/trials/a-multicenter-placebo-controlled-double-blind-study-to-evaluate-the-efficacy-and-safety-of-sandostatin-sms-201-995-in-pa-134649https://curecurrent.com/trials/prospective-comparison-of-ampicillin-amoxicillin-versus-ceftriaxone-for-the-treatment-of-salmonella-infections-in-aids-p-134650https://curecurrent.com/trials/comparison-of-gw433908-and-nelfinavir-in-hiv-patients-who-have-not-had-antiretroviral-therapy-134651https://curecurrent.com/trials/a-study-of-1592u89-in-hiv-infected-children-134652https://curecurrent.com/trials/effect-of-indinavir-plus-two-other-anti-hiv-drugs-on-blood-clotting-in-hiv-positive-males-with-hemophilia-134653https://curecurrent.com/trials/the-efficacy-and-safety-of-retrovir-in-patients-infected-with-hiv-who-are-asymptomatic-cdc-group-ii-or-have-persistent-g-134654https://curecurrent.com/trials/the-safety-of-tenofovir-disoproxil-fumarate-taken-with-other-anti-hiv-drugs-to-treat-hiv-infected-patients-134655https://curecurrent.com/trials/phase-iii-multicenter-open-label-randomized-trial-of-induction-versus-induction-plus-maintenance-foscarnet-foscavir-ther-134656https://curecurrent.com/trials/the-safety-and-effectiveness-of-peridex-in-preventing-or-delaying-fungal-infections-of-the-mouth-in-hiv-infected-patient-134657https://curecurrent.com/trials/a-study-of-valacyclovir-as-treatment-for-genital-herpes-simplex-virus-in-hiv-infected-patients-134658https://curecurrent.com/trials/a-double-blind-placebo-controlled-study-with-open-label-follow-up-to-determine-the-safety-and-efficacy-of-r-huepo-in-aid-134659https://curecurrent.com/trials/a-study-of-neutrexin-plus-leucovorin-in-the-treatment-of-pneumocystis-carinii-pneumonia-pcp-134660https://curecurrent.com/trials/an-open-study-of-the-effect-of-itraconazole-oral-solution-for-the-treatment-of-fluconazole-refractory-oropharyngeal-cand-134661https://curecurrent.com/trials/a-randomized-multicenter-double-blind-parallel-group-placebo-controlled-trial-of-the-efficacy-and-safety-of-bovine-anti-134662https://curecurrent.com/trials/safety-and-effectiveness-of-tenofovir-disoproxil-fumarate-tenofovir-df-plus-other-anti-hiv-drugs-in-hiv-infected-patient-134663https://curecurrent.com/trials/a-comparison-of-the-safety-and-effectiveness-of-fluconazole-or-clotrimazole-in-the-treatment-of-fungal-infections-of-the-134664https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-effectiveness-of-a-new-non-nucleoside-reverse-transcriptase-inhibitor-nnrti-calanolid-134665https://curecurrent.com/trials/a-comparison-of-882c87-versus-acyclovir-in-the-treatment-of-herpes-zoster-in-patients-with-weakened-immune-systems-134666https://curecurrent.com/trials/a-study-of-1592u89-in-combination-with-protease-inhibitors-in-hiv-infected-patients-who-have-never-taken-anti-hiv-drugs-134667https://curecurrent.com/trials/a-study-of-three-drug-combination-therapies-in-hiv-infected-patients-who-have-never-been-treated-with-anti-hiv-drugs-134668https://curecurrent.com/trials/a-study-of-saquinavir-soft-gelatin-capsules-combined-with-other-anti-hiv-drugs-in-hiv-1-infected-patients-134669https://curecurrent.com/trials/a-study-of-mkc-442-in-hiv-positive-patients-134670https://curecurrent.com/trials/effectiveness-of-aidsvax-b-e-vaccine-in-intravenous-drug-users-in-bangkok-thailand-134671https://curecurrent.com/trials/treatment-of-aids-and-aids-related-complex-part-1-treatment-of-patients-with-arc-azt-vs-placebo-134672https://curecurrent.com/trials/a-study-of-tucaresol-in-hiv-infected-patients-who-are-taking-other-anti-hiv-drugs-134673https://curecurrent.com/trials/the-safety-and-effectiveness-of-ganciclovir-plus-interferon-beta-in-preventing-the-return-of-cytomegalovirus-cmv-of-the-134674https://curecurrent.com/trials/a-phase-i-observer-blind-placebo-controlled-study-of-the-chiron-vaccine-hiv-p24-mf59-administered-to-healthy-hiv-seroneg-134675https://curecurrent.com/trials/safety-and-effectiveness-of-cpi-1189-in-hiv-infected-males-on-combination-anti-hiv-drug-therapy-134676https://curecurrent.com/trials/intracellular-pharmacokinetics-of-zidovudine-triphosphate-in-maternal-and-infant-cord-blood-mononuclear-cells-134677https://curecurrent.com/trials/a-phase-iii-randomized-double-blind-multicenter-study-to-evaluate-the-safety-and-efficacy-of-3tc-zdv-1592u89-and-3tc-zdv-134678https://curecurrent.com/trials/safety-and-effectiveness-of-trizivir-abacavir-lamivudine-zidovudine-with-efavirenz-in-hiv-infected-patients-who-have-nev-134679https://curecurrent.com/trials/sp-303t-applied-to-the-skin-of-patients-with-herpes-simplex-virus-hsv-infection-and-aids-who-have-not-had-success-with-a-134680https://curecurrent.com/trials/an-open-label-evaluation-of-the-safety-and-pharmacokinetics-of-ganciclovir-in-children-134681https://curecurrent.com/trials/an-open-label-study-of-the-use-of-azithromycin-in-patients-with-symptomatic-disseminated-mycobacterium-avium-intracellul-134682https://curecurrent.com/trials/a-treatment-ind-for-566c80-therapy-of-pneumocystis-carinii-pneumonia-134683https://curecurrent.com/trials/a-phase-ii-iii-study-of-cysteamine-mercaptoethylamine-and-zidovudine-for-the-treatment-of-hiv-disease-134684https://curecurrent.com/trials/the-safety-and-effectiveness-of-rmp-7-plus-amphotericin-b-in-patients-with-hiv-and-cryptococcal-meningitis-134685https://curecurrent.com/trials/open-non-comparative-study-of-intravenous-and-oral-fluconazole-in-the-treatment-of-acute-cryptococcal-meningitis-134686https://curecurrent.com/trials/a-double-blind-placebo-controlled-trial-of-albendazole-in-hiv-positive-patients-with-intestinal-microsporidiosis-134687https://curecurrent.com/trials/su5416-in-patients-with-aids-related-kaposi-s-sarcoma-who-have-not-responded-to-treatment-134688https://curecurrent.com/trials/a-multi-center-open-label-ascending-multiple-oral-dose-safety-tolerance-and-pharmacokinetic-study-of-3-deoxy-3-fluorothy-134689https://curecurrent.com/trials/phase-i-ii-study-of-curdlan-sulfate-134690https://curecurrent.com/trials/a-study-of-amprenavir-in-hiv-infected-patients-134691https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-trial-of-ubi-synvac-hiv-1-mn-octameric-v3-peptide-vaccine-134692https://curecurrent.com/trials/a-study-of-genevax-hiv-a-possible-vaccine-134693https://curecurrent.com/trials/a-comparison-of-three-anti-hiv-drug-combinations-containing-saquinavir-soft-gelatin-capsules-used-in-hiv-1-infected-pati-134694https://curecurrent.com/trials/the-safety-and-effectiveness-of-lamivudine-plus-zidovudine-used-with-and-without-1592u89-in-hiv-1-infected-patients-who-134695https://curecurrent.com/trials/a-multicenter-study-of-oral-versus-intravenous-hydration-in-aids-patients-with-cmv-retinitis-treated-with-foscavir-fosca-134696https://curecurrent.com/trials/depot-disulfiram-for-aids-and-arc-134697https://curecurrent.com/trials/a-study-of-combivir-plus-abacavir-plus-141w94-in-patients-who-previously-have-used-anti-hiv-drugs-134698https://curecurrent.com/trials/a-prospective-double-blind-study-of-retrovir-in-early-hiv-infection-134699https://curecurrent.com/trials/the-safety-and-effectiveness-of-zidovudine-plus-acyclovir-in-patients-with-early-hiv-infection-134700https://curecurrent.com/trials/detection-of-human-immunodeficiency-virus-type-1-hiv-1-in-vaginocervical-secretions-correlation-with-clinical-status-vir-134701https://curecurrent.com/trials/the-safety-and-effectiveness-of-indinavir-sulfate-plus-efavirenz-134702https://curecurrent.com/trials/an-open-label-phase-i-ii-study-of-recombinant-granulocyte-colony-stimulating-factor-r-methug-csf-and-recombinant-erythro-134703https://curecurrent.com/trials/a-study-of-thymic-humoral-factor-thf-gamma-2-in-hiv-infected-patients-134704https://curecurrent.com/trials/a-double-blind-randomized-placebo-controlled-multicenter-study-to-assess-the-efficacy-and-safety-of-orally-administered-134705https://curecurrent.com/trials/effectiveness-and-safety-of-epivir-ziagen-zerit-3tc-abc-d4t-versus-epivir-ziagen-sustiva-3tc-abc-efv-versus-epivir-ziage-134706https://curecurrent.com/trials/a-randomized-open-comparative-multicenter-study-of-initial-treatment-with-intravenous-itraconazole-versus-amphotericin-b-134707https://curecurrent.com/trials/indinavir-plus-efavirenz-plus-adefovir-dipivoxil-in-hiv-infected-patients-who-have-not-had-success-with-nelfinavir-134708https://curecurrent.com/trials/a-study-of-hiv-and-cytomegalovirus-cmv-in-hiv-infected-patients-134709https://curecurrent.com/trials/an-open-label-crossover-study-to-assess-the-effect-of-food-on-the-oral-bioavailability-and-pharmacokinetic-profile-of-3-134710https://curecurrent.com/trials/a-phase-i-trial-to-evaluate-the-safety-and-immunogenicity-of-the-ubi-hiv-1mn-pnd-peptide-immunogen-given-by-im-injection-134711https://curecurrent.com/trials/paclitaxel-in-advanced-refractory-kaposi-s-sarcoma-aids-ks-a-phase-ii-trial-of-paclitaxel-from-baker-norton-pharmaceutic-134712https://curecurrent.com/trials/a-double-blind-randomized-parallel-group-study-comparing-procysteine-to-placebo-in-hiv-infected-patients-who-are-taking-134713https://curecurrent.com/trials/a-comparison-of-two-dose-levels-of-indinavir-combined-with-two-nucleoside-analogue-reverse-transcriptase-inhibitors-nrti-134714https://curecurrent.com/trials/the-safety-and-effectiveness-of-u-90152-in-hiv-1-infected-patients-who-take-zidovudine-134715https://curecurrent.com/trials/a-study-of-1592u89-in-hiv-infected-patients-134716https://curecurrent.com/trials/azithromycin-in-the-treatment-of-cryptosporidiosis-in-patients-who-have-not-had-success-with-other-drugs-134717https://curecurrent.com/trials/phase-i-study-of-the-clinical-pharmacology-of-azithromycin-in-buffy-coat-of-hiv-infected-subjects-134718https://curecurrent.com/trials/the-safety-and-effectiveness-of-935u83-in-hiv-infected-patients-134719https://curecurrent.com/trials/a-phase-i-open-label-trial-to-evaluate-the-safety-tolerance-and-biological-effects-of-sdz-ile-964-recombinant-human-inte-134720https://curecurrent.com/trials/a-randomized-double-blind-study-of-mkc-442-combined-with-viracept-in-patients-who-are-epivir-retrovir-experienced-and-ar-134721https://curecurrent.com/trials/a-study-of-indinavir-taken-with-or-without-dmp-266-134722https://curecurrent.com/trials/pharmacokinetics-of-nystatin-lf-i-v-in-patients-with-acquired-immune-deficiency-syndrome-related-complex-arc-134723https://curecurrent.com/trials/comparison-of-gw433908-ritonavir-to-nelfinavir-when-used-with-abacavir-and-lamivudine-in-patients-that-have-not-taken-an-134724https://curecurrent.com/trials/a-study-of-two-anti-hiv-drug-combinations-134725https://curecurrent.com/trials/an-open-label-study-to-evaluate-the-efficacy-and-safety-of-amprenavir-141w94-and-abacavir-combination-therapy-in-proteas-134726https://curecurrent.com/trials/the-safety-and-effectiveness-of-mk-639-and-zidovudine-used-alone-and-together-in-hiv-infected-patients-who-have-never-ta-134727https://curecurrent.com/trials/a-multicenter-comparison-of-fluconazole-uk-49-858-and-amphotericin-b-as-treatment-for-acute-cryptococcal-meningitis-134728https://curecurrent.com/trials/double-blind-randomized-dose-ranging-study-of-alferon-ldo-low-dose-oral-interferon-alfa-n3-human-leukocyte-derived-in-hi-134729https://curecurrent.com/trials/a-phase-ii-open-randomized-comparison-of-566c80-and-pentamidine-isethionate-for-the-treatment-of-pneumocystis-carinii-pn-134730https://curecurrent.com/trials/study-of-enfuvirtide-in-hiv-positive-subjects-134731https://curecurrent.com/trials/the-safety-and-effectiveness-of-fozivudine-tidoxil-in-hiv-1-infected-patients-134732https://curecurrent.com/trials/a-study-of-t-20-in-hiv-positive-adults-134733https://curecurrent.com/trials/a-comparison-of-three-anti-hiv-drug-combinations-in-hiv-infected-patients-134734https://curecurrent.com/trials/evaluation-of-the-therapeutic-benefit-of-r-methuifn-gamma-in-aids-patients-with-disseminated-mycobacterium-avium-intrace-134735https://curecurrent.com/trials/the-safety-and-effectiveness-of-hby-097-used-with-or-without-azt-in-hiv-infected-patients-who-have-mild-or-no-symptoms-134736https://curecurrent.com/trials/a-multi-center-placebo-controlled-double-blind-randomized-trial-comparing-the-virologic-and-immunologic-activities-of-40-134737https://curecurrent.com/trials/a-phase-i-trial-to-evaluate-the-safety-pharmacokinetics-and-antiviral-activity-of-141w94-after-multiple-dosing-in-patien-134738https://curecurrent.com/trials/tenofovir-disoproxil-fumarate-tdf-in-hiv-1-patients-who-have-never-taken-anti-hiv-drugs-134739https://curecurrent.com/trials/a-double-blind-randomized-comparative-study-of-delavirdine-mesylate-u-90152s-in-combination-with-didanosine-ddi-versus-d-134740https://curecurrent.com/trials/the-safety-and-effectiveness-of-adefovir-dipivoxil-in-hiv-infected-children-134741https://curecurrent.com/trials/a-double-blind-group-comparative-study-to-evaluate-the-long-term-safety-and-effectiveness-of-two-different-doses-of-aero-134742https://curecurrent.com/trials/a-study-of-the-safety-and-tolerance-of-long-term-therapy-with-intravenous-cytovene-ganciclovir-sodium-for-cytomegaloviru-134743https://curecurrent.com/trials/a-study-of-peldesine-bcx-34-in-hiv-infected-patients-134744https://curecurrent.com/trials/the-safety-and-effectiveness-of-spc3-in-hiv-1-infected-patients-134745https://curecurrent.com/trials/the-safety-and-effectiveness-of-retrovir-plus-hivid-combined-with-either-nevirapine-or-invirase-in-the-treatment-of-hiv-134746https://curecurrent.com/trials/the-safety-and-effectiveness-of-pmpa-prodrug-in-hiv-infected-patients-134747https://curecurrent.com/trials/rifabutin-therapy-for-the-prevention-of-mycobacterium-avium-complex-mac-bacteremia-in-hiv-positive-patients-with-cd4-cou-134748https://curecurrent.com/trials/a-phase-i-maximum-tolerated-dose-study-of-ci-1012-in-late-stage-hiv-patients-134749https://curecurrent.com/trials/a-phase-ii-open-label-exploratory-study-of-saquinavir-zidovudine-lamivudine-in-hiv-infected-patients-134750https://curecurrent.com/trials/an-open-non-comparative-study-of-intravenous-and-oral-fluconazole-in-the-treatment-of-acute-cryptococcal-meningitis-134751https://curecurrent.com/trials/oral-manifestations-of-human-immunodeficiency-virus-infection-in-high-risk-groups-134752https://curecurrent.com/trials/a-study-of-saquinavir-soft-gelatin-capsules-plus-zidovudine-plus-lamivudine-in-the-treatment-of-hiv-1-infected-patients-134753https://curecurrent.com/trials/the-effect-of-teaching-hiv-infected-patients-about-hiv-and-treatment-134754https://curecurrent.com/trials/a-study-of-increased-lactic-acid-and-abnormal-fat-distribution-in-hiv-positive-patients-134755https://curecurrent.com/trials/safety-and-effectiveness-of-giving-adefovir-preveon-plus-other-anti-hiv-drugs-to-hiv-infected-patients-who-have-not-resp-134756https://curecurrent.com/trials/treatment-of-advanced-aids-patients-with-dextrin-sulfate-134757https://curecurrent.com/trials/randomized-placebo-controlled-study-of-aerobic-exercise-and-resistance-training-plus-megestrol-acetate-for-hiv-wasting-134758https://curecurrent.com/trials/the-safety-and-effectiveness-of-r-huepo-in-patients-with-aids-and-anemia-caused-by-aids-and-treatment-with-azt-134759https://curecurrent.com/trials/a-study-on-the-safety-and-effectiveness-of-twice-daily-nelfinavir-plus-twice-daily-indinavir-plus-efavirenz-in-hiv-posit-134760https://curecurrent.com/trials/safety-and-effectiveness-of-a-combination-anti-hiv-drug-treatment-134761https://curecurrent.com/trials/a-comparison-of-fluconazole-and-amphotericin-b-in-the-treatment-of-cryptococcal-meningitis-134762https://curecurrent.com/trials/a-phase-i-trial-of-tecogalan-sodium-ds-4152-administered-as-an-infusion-weekly-x-4-134763https://curecurrent.com/trials/gene-therapy-in-hiv-positive-patients-with-non-hodgkin-s-lymphoma-134764https://curecurrent.com/trials/toxoplasmic-encephalitis-in-patients-with-aids-treatment-and-prevention-of-relapse-134765https://curecurrent.com/trials/the-effects-of-illnesses-on-hiv-levels-in-the-body-134766https://curecurrent.com/trials/tnx-355-with-optimized-background-therapy-obt-in-treatment-experienced-subjects-with-hiv-1-134767https://curecurrent.com/trials/safety-and-effectiveness-of-an-anti-hiv-drug-combination-taken-twice-daily-134768https://curecurrent.com/trials/safety-and-effectiveness-of-zintevir-ar177-given-to-hiv-infected-patients-134769https://curecurrent.com/trials/phase-ii-randomized-study-of-cidofovir-for-peripheral-cytomegalovirus-retinitis-134770https://curecurrent.com/trials/a-compassionate-treatment-protocol-for-the-use-of-trimetrexate-glucuronate-neutrexin-with-leucovorin-protection-for-euro-134771https://curecurrent.com/trials/an-expanded-access-open-label-protocol-of-remune-hiv-1-immunogen-in-hiv-1-infected-adults-with-cd4-count-550-cells-ml-an-134772https://curecurrent.com/trials/dideoxycytidine-ro-24-2027-a-treatment-protocol-for-the-use-of-dideoxycytidine-ddc-in-patients-with-aids-or-advanced-arc-134773https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-different-doses-of-1592u89-in-hiv-infected-patients-134774https://curecurrent.com/trials/the-safety-and-effectiveness-of-pentamidine-in-the-prevention-of-pneumocystis-carinii-pneumonia-pcp-in-patients-with-aid-134775https://curecurrent.com/trials/open-label-program-of-dideoxycytidine-ddc-to-be-used-in-combination-with-zidovudine-azt-for-treatment-of-advanced-hiv-di-134776https://curecurrent.com/trials/safety-and-effectiveness-of-giving-lamisil-to-hiv-positive-subjects-with-thrush-who-have-not-responded-to-fluconazole-tr-134777https://curecurrent.com/trials/a-double-blind-study-to-evaluate-the-safety-and-pharmacokinetics-of-l-ofloxacin-rwj-25213-in-subjects-with-hiv-infection-134778https://curecurrent.com/trials/a-study-of-isoprinosine-in-patients-with-severe-aids-134779https://curecurrent.com/trials/tolerance-safety-and-activity-of-rifapentine-alone-and-in-combination-therapy-in-aids-patients-with-mycobacterium-avium-134780https://curecurrent.com/trials/rosiglitazone-in-the-treatment-of-hiv-associated-hyperlipidemia-134781https://curecurrent.com/trials/a-pilot-randomized-double-blind-placebo-controlled-parallel-design-multicenter-trial-to-evaluate-the-effect-of-ranitidin-134782https://curecurrent.com/trials/a-phase-i-trial-of-tecogalan-sodium-ds-4152-administered-as-an-infusion-every-21-days-134783https://curecurrent.com/trials/emtricitabine-given-once-a-day-with-other-anti-hiv-drugs-in-children-with-hiv-134784https://curecurrent.com/trials/a-study-of-alrt1057-in-patients-with-aids-related-kaposi-s-sarcoma-134785https://curecurrent.com/trials/an-open-label-study-of-the-safety-and-efficacy-of-cidofovir-for-the-treatment-of-relapsing-cytomegalovirus-retinitis-in-134786https://curecurrent.com/trials/a-study-of-efavirenz-in-combination-with-stavudine-and-didanosine-134787https://curecurrent.com/trials/a-study-of-fluconazole-in-the-treatment-of-cryptococcal-meningitis-in-patients-who-have-not-had-success-with-amphoterici-134788https://curecurrent.com/trials/the-safety-and-effectiveness-of-nevirapine-plus-nelfinavir-in-hiv-1-infected-patients-who-have-taken-stavudine-134789https://curecurrent.com/trials/a-study-of-isis-2922-in-the-treatment-of-advanced-cytomegalovirus-retinitis-134790https://curecurrent.com/trials/safety-and-effectiveness-of-giving-two-nucleoside-reverse-transcriptase-inhibitors-alone-or-in-combination-with-141w94-t-134791https://curecurrent.com/trials/an-open-label-study-in-hiv-patients-to-determine-the-effects-of-nevirapine-viramune-on-the-pharmacokinetics-of-clarithro-134792https://curecurrent.com/trials/a-study-of-spiramycin-in-the-treatment-of-patients-with-aids-related-diarrhea-134793https://curecurrent.com/trials/a-comparison-of-emtricitabine-and-abacavir-used-in-a-three-drug-combination-in-hiv-infected-patients-who-have-never-take-134794https://curecurrent.com/trials/a-randomized-open-label-study-of-alternative-treatment-combinations-of-dideoxycytidine-hivid-ddc-and-zidovudine-azt-in-p-134795https://curecurrent.com/trials/safety-and-efficacy-of-intravenous-magnesium-sulfate-in-modulating-changes-in-symptoms-and-divalent-cation-levels-associ-134796https://curecurrent.com/trials/safety-and-effectiveness-of-adding-pmpa-prodrug-to-an-anti-hiv-drug-combination-to-treat-hiv-infected-patients-134797https://curecurrent.com/trials/multicenter-comparison-of-fluconazole-uk-49-858-and-amphotericin-b-as-maintenance-treatment-for-the-prevention-of-relaps-134798https://curecurrent.com/trials/a-study-of-two-forms-of-pentamidine-in-the-treatment-of-pneumocystis-carinii-pneumonia-pcp-in-patients-with-aids-134799https://curecurrent.com/trials/a-study-of-1592u89-combined-with-other-anti-hiv-drugs-in-patients-who-have-taken-anti-hiv-drugs-134800https://curecurrent.com/trials/a-phase-i-ii-pilot-study-of-simultaneously-administered-rhu-gm-csf-cho-cell-and-azidothymidine-azt-in-patients-with-seve-134801https://curecurrent.com/trials/safety-and-effectiveness-of-giving-su5416-to-hiv-infected-patients-with-aids-related-kaposi-s-sarcoma-134802https://curecurrent.com/trials/a-study-of-multiple-doses-of-vesnarinone-in-advanced-hiv-disease-134803https://curecurrent.com/trials/a-compassionate-use-study-of-tenofovir-disoproxil-fumarate-as-treatment-for-hiv-infection-134804https://curecurrent.com/trials/acupuncture-and-herbal-treatment-of-chronic-hiv-sinusitis-134805https://curecurrent.com/trials/safety-and-effectiveness-of-a-new-anti-hiv-drug-ag1549-in-combination-with-other-anti-hiv-drugs-in-hiv-infected-patients-134806https://curecurrent.com/trials/diethylhomospermine-dehspm-for-refractory-aids-related-diarrhea-134807https://curecurrent.com/trials/a-study-to-compare-the-efficacy-and-safety-of-valacyclovir-hydrochloride-256u87-versus-acyclovir-in-the-treatment-of-rec-134808https://curecurrent.com/trials/a-pilot-study-to-evaluate-the-effects-of-subcutaneously-administered-recombinant-human-granulocyte-macrophage-colony-sti-134809https://curecurrent.com/trials/phase-i-rising-dose-tolerability-study-of-sc-48334-in-patients-with-acquired-immunodeficiency-syndrome-aids-and-advanced-134810https://curecurrent.com/trials/a-phase-i-study-of-the-safety-and-immunogenicity-of-rgp-120-hiv-1iiib-vaccine-in-hiv-1-seropositive-adult-volunteers-134811https://curecurrent.com/trials/effectiveness-of-a-new-anti-hiv-drug-ag1549-plus-viracept-nelfinavir-plus-combivir-zidovudine-lamivudine-in-hiv-infected-134812https://curecurrent.com/trials/a-study-of-valganciclovir-in-the-treatment-of-cytomegalovirus-cmv-retinitis-in-patients-with-aids-134813https://curecurrent.com/trials/a-double-blind-study-to-evaluate-the-long-term-safety-and-effectiveness-of-60-mg-versus-120-mg-of-aerosol-pentamidine-in-134814https://curecurrent.com/trials/an-open-label-safety-program-for-the-use-of-zalcitabine-dideoxycytidine-ddc-in-pediatric-patients-with-symptomatic-hiv-i-134815https://curecurrent.com/trials/an-open-label-study-to-evaluate-the-long-term-safety-and-effectiveness-of-aerosol-pentamidine-in-the-prophylaxis-of-pneu-134816https://curecurrent.com/trials/an-open-multicenter-study-of-foscarnet-treatment-of-acyclovir-resistant-herpes-simplex-virus-in-patients-with-the-acquir-134817https://curecurrent.com/trials/a-double-blind-placebo-controlled-study-to-determine-the-optimal-immunopharmacological-dose-level-of-isoprinosine-in-imm-134818https://curecurrent.com/trials/double-blind-study-of-thymopentin-effects-on-patients-with-hiv-1-infection-134819https://curecurrent.com/trials/a-study-of-indinavir-sulfate-given-together-with-stavudine-to-hiv-positive-patients-134820https://curecurrent.com/trials/double-blind-placebo-controlled-study-comparing-the-combination-of-15-sp-303-gel-with-acyclovir-versus-acyclovir-alone-f-134821https://curecurrent.com/trials/the-safety-and-effectiveness-of-isis-2922-in-patients-with-aids-who-have-cytomegalovirus-cmv-of-the-eyes-134822https://curecurrent.com/trials/a-randomized-study-of-daily-and-intermittent-prophylactic-regimens-for-the-prevention-of-disseminated-mycobacterium-aviu-134823https://curecurrent.com/trials/safety-and-efficacy-of-polyethylene-glycolated-il-2-peg-il-2-plus-zidovudine-or-dideoxyinosine-in-hiv-positive-asymptoma-134824https://curecurrent.com/trials/the-safety-and-effectiveness-of-bis-pom-pmea-in-hiv-infected-patients-134825https://curecurrent.com/trials/a-study-of-saquinavir-used-alone-or-in-combination-with-other-anti-hiv-drugs-in-hiv-infected-patients-134826https://curecurrent.com/trials/a-randomized-phase-ii-efficacy-activity-and-safety-study-of-glq223-alone-and-in-combination-with-zidovudine-in-symptomat-134827https://curecurrent.com/trials/heterosexual-hiv-transmission-study-hats-prospective-cohort-study-134828https://curecurrent.com/trials/a-study-of-retrovir-in-the-prevention-of-hiv-infection-in-health-care-workers-accidentally-exposed-to-the-virus-134829https://curecurrent.com/trials/the-safety-of-four-different-dose-levels-of-wobenzym-in-hiv-positive-patients-134830https://curecurrent.com/trials/epicutaneous-1-chloro-2-4-dinitrobenzene-dncb-patch-in-hiv-infection-134831https://curecurrent.com/trials/a-phase-i-ii-safety-and-immunogenicity-trial-of-ubi-microparticulate-monovalent-hiv-1-mn-branched-peptide-vaccine-in-hiv-134832https://curecurrent.com/trials/safety-and-effectiveness-of-adding-saquinavir-fortovase-in-soft-gel-capsule-form-to-an-anti-hiv-drug-combination-in-hiv-134833https://curecurrent.com/trials/a-study-of-dox-sl-in-the-treatment-of-aids-related-kaposi-s-sarcoma-134834https://curecurrent.com/trials/safety-and-effectiveness-of-nitazoxanide-for-the-treatment-of-cryptosporidiosis-in-aids-patients-134835https://curecurrent.com/trials/a-randomized-double-blind-active-controlled-dose-ranging-study-of-the-safety-and-efficacy-of-chronically-administered-md-134836https://curecurrent.com/trials/a-multi-center-randomized-double-blind-placebo-controlled-study-to-investigate-the-effect-of-isoprinosine-in-immunodepre-134837https://curecurrent.com/trials/prospective-open-label-study-of-the-emergence-of-drug-resistance-in-patients-infected-with-hiv-1-who-are-taking-oral-u-8-134838https://curecurrent.com/trials/effects-of-home-visits-on-medication-adherence-in-children-and-youth-with-hiv-134839https://curecurrent.com/trials/safety-and-effectiveness-of-treating-hiv-positive-patients-with-an-hiv-vaccine-remune-134840https://curecurrent.com/trials/study-of-itraconazole-in-patients-with-advanced-hiv-infection-134841https://curecurrent.com/trials/a-study-of-retrovir-in-the-treatment-of-psoriasis-in-hiv-positive-patients-134842https://curecurrent.com/trials/a-study-of-alrt-1057-topical-gel-in-patients-with-aids-related-kaposi-s-sarcoma-134843https://curecurrent.com/trials/an-open-parallel-study-to-determine-the-optimum-dosing-schedule-for-as-101-in-aids-arc-patients-134844https://curecurrent.com/trials/safety-and-effects-of-giving-a-new-hiv-vaccine-genevax-hiv-to-hiv-negative-volunteers-134845https://curecurrent.com/trials/double-blind-study-of-thymopentin-effects-on-patients-with-hiv-1-infection-134846https://curecurrent.com/trials/a-phase-i-study-of-recombinant-cd4-rcd4-in-patients-with-aids-and-aids-related-complex-134847https://curecurrent.com/trials/pilot-study-of-oral-fluconazole-in-the-treatment-of-acute-cryptococcal-meningitis-134848https://curecurrent.com/trials/an-open-label-phase-i-study-of-subcutaneously-administered-recombinant-human-gm-csf-in-patients-with-aids-virus-infectio-134849https://curecurrent.com/trials/comparing-side-effects-of-two-forms-of-videx-in-hiv-infected-adults-134850https://curecurrent.com/trials/a-randomized-phase-i-ii-trial-to-assess-the-safety-and-antiviral-effects-of-escalating-doses-of-a-human-anti-cytomegalov-134851https://curecurrent.com/trials/safety-and-effectiveness-of-topotecan-hcl-to-treat-hiv-infected-patients-with-aids-related-progressive-multifocal-leukoe-134852https://curecurrent.com/trials/compassionate-use-study-of-two-dose-levels-of-thalidomide-in-adults-with-hiv-wasting-syndrome-134853https://curecurrent.com/trials/a-study-of-mdl-28-574a-in-hiv-infected-patients-134854https://curecurrent.com/trials/a-double-blind-randomized-dose-response-study-of-three-doses-of-delavirdine-mesylate-u-90152s-in-combination-with-zidovu-134855https://curecurrent.com/trials/a-study-of-itraconazole-in-the-prevention-of-histoplasmosis-a-fungal-infection-in-hiv-infected-patients-134856https://curecurrent.com/trials/retrovir-capsules-in-the-treatment-of-hiv-infected-patients-in-renal-failure-134857https://curecurrent.com/trials/safety-and-efficacy-of-amphotericin-b-lipid-complex-in-the-treatment-of-cryptococcal-meningitis-in-patients-with-the-acq-134858https://curecurrent.com/trials/a-comparison-of-sch-56592-and-fluconazole-in-the-treatment-of-oropharyngeal-candidiasis-opc-in-hiv-positive-patients-134859https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-effectiveness-of-wf10-given-to-patients-with-late-stage-hiv-disease-134860https://curecurrent.com/trials/a-study-of-lxr015-1-in-hiv-infected-patients-134861https://curecurrent.com/trials/phase-i-study-of-alferon-n-injection-in-persons-with-asymptomatic-human-immunodeficiency-virus-hiv-infection-134862https://curecurrent.com/trials/a-study-of-mkc-442-in-combination-with-other-anti-hiv-drugs-134863https://curecurrent.com/trials/abt-378-ritonavir-and-efavirenz-in-hiv-infected-patients-who-have-taken-more-than-one-protease-inhibitor-in-the-past-134864https://curecurrent.com/trials/further-evaluation-of-thalidomide-s-ability-to-potentiate-the-immune-response-to-hiv-infected-patients-134865https://curecurrent.com/trials/a-study-of-aidsvax-b-b-and-aidsvax-b-e-two-possible-vaccines-134866https://curecurrent.com/trials/a-study-of-ci-1012-in-hiv-infected-patients-134867https://curecurrent.com/trials/a-phase-i-trial-of-apl-400-003-vaccine-safety-and-immune-response-evaluations-of-multiple-injections-at-escalating-doses-134868https://curecurrent.com/trials/treatment-of-patients-with-human-immunodeficiency-virus-hiv-related-chronic-diarrhea-with-saccharomyces-boulardii-or-pla-134869https://curecurrent.com/trials/an-open-label-non-randomized-trial-to-evaluate-the-tolerability-and-safety-of-viramune-nevirapine-in-adult-and-pediatric-134870https://curecurrent.com/trials/safety-and-effectiveness-of-giving-indinavir-and-nelfinavir-to-hiv-infected-patients-134871https://curecurrent.com/trials/a-comparison-of-141w94-and-indinavir-in-hiv-infected-patients-134872https://curecurrent.com/trials/a-phase-i-study-of-the-safety-and-pharmacokinetics-of-recombinant-cd4-rcd4-in-patients-with-aids-and-aids-related-comple-134873https://curecurrent.com/trials/a-study-of-the-side-effects-of-l-743-872-in-men-with-candidal-esophagitis-134874https://curecurrent.com/trials/a-phase-i-ii-clinical-study-of-wf-10-iv-solution-tcdo-in-patients-with-hiv-infection-134875https://curecurrent.com/trials/a-study-of-two-forms-of-ganciclovir-in-the-treatment-of-cytomegalovirus-cmv-of-the-eyes-in-patients-with-aids-134876https://curecurrent.com/trials/rifabutin-therapy-for-the-prevention-of-mycobacterium-avium-complex-mac-bacteremia-in-aids-patients-with-cd4-counts-or-2-134877https://curecurrent.com/trials/the-therakos-uvar-photopheresis-system-in-the-treatment-of-aids-related-complex-134878https://curecurrent.com/trials/a-study-of-timunox-thymopentin-in-hiv-infected-patients-receiving-other-anti-hiv-drugs-134879https://curecurrent.com/trials/a-study-of-viracept-in-aids-patients-with-mycobacterium-avium-complex-disease-mac-134880https://curecurrent.com/trials/a-phase-i-study-of-the-safety-and-pharmacokinetics-of-recombinant-cd4-immunoglobulin-g-rcd4-igg-in-hiv-1-seropositive-wo-134881https://curecurrent.com/trials/a-multicenter-double-blind-controlled-study-to-evaluate-ampligen-134882https://curecurrent.com/trials/a-study-to-compare-the-safety-and-effectiveness-of-two-dosing-schedules-of-lamivudine-in-combination-with-two-other-anti-134883https://curecurrent.com/trials/a-study-of-tecogalan-sodium-134884https://curecurrent.com/trials/safety-and-effectiveness-of-giving-l-743-872-to-patients-with-thrush-that-has-not-been-cured-with-fluconazole-134885https://curecurrent.com/trials/immunomodulation-of-hiv-1-infected-individuals-with-peg-interleukin-2-134886